NCT06189157
MB-CART19.1 in Refractory SLE treatment 1 / 2 not_yet_recruiting NCT04234633
Effect of Gender on Clinical Presentation of SLE ِAt Assiut University Hospitals No drug interventions Not Available Not Available unknown_status NCT01031797
QT Dispersion in Patients With Systemic Lupus Erythematosus (SLE) No drug interventions Not Available Not Available completed NCT01207297
Tacrolimus Versus Cyclophosphamide as Treatment for Lupus Nephritis treatment 1 completed NCT05161988
Serum IL 26 as a Marker of Disease Activity in SLE No drug interventions Not Available Not Available not_yet_recruiting NCT05342285
Flow Mediated Dilation in Association With Hyperuricemia No drug interventions Not Available Not Available unknown_status NCT00275899
Role of DcR3 in T Cell Activation in SLE and RA No drug interventions Not Available Not Available unknown_status NCT04368299
Telemedicine for Follow-up of Systemic Lupus Erythematosus No drug interventions health_services_research Not Available completed NCT04806113
COVID-19 Vaccine in Immunosuppressed Adults With Autoimmune Diseases prevention 3 completed NCT05822219
Vaccine Hesitancy in Black/African Americans With Rheumatic Diseases No drug interventions health_services_research Not Available recruiting NCT06570434
Phase 1b/2a in SLE With Budoputug treatment 1 / 2 not_yet_recruiting NCT05230316
Gynecological Symptoms and Health-related Quality of Life in Egyptian Women With SLE No drug interventions Not Available Not Available active_not_recruiting NCT04018222
Translation of a Diagnostic Test for Lupus Flare Prediction From Bench to Clinic No drug interventions Not Available Not Available unknown_status NCT06445127
Evaluation of Patients With Lupus Nephritis Using Kidney MRI (Magnetic Resonance Imaging) No drug interventions diagnostic Not Available recruiting NCT04392791
Does Balnotherapy Influence the Qualitiy of Life in SLE No drug interventions supportive_care Not Available completed NCT05966480
Phase 2 Placebo-Controlled Study to Assess the Safety and Efficacy of ESK-001 in Active Systemic Lupus Erythematosus No drug interventions treatment 2 recruiting NCT06581029
Evaluating Mental Health Challenges in Juvenile Lupus Erythematosus and Their Caregivers No drug interventions Not Available Not Available not_yet_recruiting NCT04517240
A Study on Protein Losing Enteropathy In Systemic Lupus Erythematosus No drug interventions Not Available Not Available unknown_status NCT00710021
Vitamin D3 in Systemic Lupus Erythematosus treatment 2 completed NCT03093402
JBT-101 in Systemic Lupus Erythematosus (SLE) treatment 2 completed NCT03155477
Effect Of Curcuma Xanthorrhiza and Vitamin D3 Supplementation in SLE Patients With Hypovitamin D No drug interventions treatment Not Available completed NCT00364728
Efferocytosis and Genomic Polymorphism in Autoimmune Diseases No drug interventions Not Available Not Available unknown_status NCT03142711
Validation of a Mobile Phone Based on EPRO Tool in Subjects With Systemic Lupus Erythematosus No drug interventions Not Available Not Available completed NCT04037293
Premature Atherosclerosis in Systemic Lupus Erythematosus No drug interventions Not Available Not Available unknown_status NCT05479071
Relation of Antibodies Against Oxidized Low Density Lipoproteins to Disease Activity and Cardiovascular Affection in Systemic Lupus. No drug interventions Not Available Not Available unknown_status NCT02240888
Vaccination in Inflammatory Rheumatic Disease (VACCIMIL). The Impact of Antirheumatic Treatment on Antibody Response No drug interventions treatment Not Available completed NCT03240536
Choosing Tests Wisely in Rheumatology No drug interventions health_services_research Not Available completed NCT02483624
3,3'-Diindolylmethane in Patients With Systemic Lupus Erythematosus treatment 1 terminated NCT03144063
Improving the Assessment of SLE Disease Activity No drug interventions Not Available Not Available unknown_status NCT01761422
Myocardial Inflammation in Systemic Lupus Erythematosus No drug interventions Not Available Not Available active_not_recruiting NCT05748925
Cardio Renal Effects of SGLT2 Inhibitors Among Lupus Nephritis Patients prevention 4 active_not_recruiting NCT03984227
New Signaling Pathway Targeting Systemic Lupus Erythematosus No drug interventions Not Available Not Available unknown_status NCT01946880
Randomized MMF Withdrawal in Systemic Lupus Erythematosus (SLE) treatment 2 terminated NCT05470569
Argentinian Prospective Registry of Patients With Lupus No drug interventions Not Available Not Available recruiting NCT06182969
A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus. treatment 1 / 2 not_yet_recruiting NCT05958446
Fetal-Hope Study: Home Monitoring of Fetal Heart Rate in SSA+ Pregnant Women No drug interventions Not Available Not Available recruiting NCT00152555
Physical Therapy for Systemic Lupus Erythematosus (SLE) No drug interventions treatment Not Available terminated NCT04604990
National Systemic Lupus Erythematosus Prospective Cohort, Saudi Arabia No drug interventions Not Available Not Available recruiting NCT04233164
Genomic Effects of Glucocorticoids in Patients With Systemic Lupus Erythematosus basic_science 0 completed NCT06335979
An Ascending Dose Study of PIT565 in Participants With Systemic Lupus Erythematosus (SLE). No drug interventions treatment 1 not_yet_recruiting NCT06420154
The Safety and Efficacy of Anti-CD19 CAR-T Cells in Patients With Relapsed/Refractory Autoimmune Diseases No drug interventions treatment 0 not_yet_recruiting NCT06150651
Safety of PiggyBac Transposon CAR T-cells Targeting CD-19 in Refractory Lupus. No drug interventions treatment 1 recruiting NCT05747651
3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erythematosus Study Protocol 2 No drug interventions Not Available Not Available recruiting NCT05567198
Gonadotropin-releasing Hormone Agonist (GnRHa) in Ovarian Preservation in SLE Subjects Receiving Cyclophosphamide as Determined by Questionnaires No drug interventions Not Available Not Available recruiting NCT05866861
A Study in Participants With Mild-to-moderate Systemic Lupus Erythematosus No drug interventions treatment 1 recruiting NCT04866615
Posterior Segment Evaluation of Patients With SLE Using OCT and OCTA No drug interventions Not Available Not Available unknown_status NCT06234852
Gradual Withdrawal of Low-dose Glucocorticoid in Clinically Quiescent Systemic Lupus Erythematosus. No drug interventions treatment Not Available completed NCT06560775
Effects of Nigella Sativa on T Cells and Cytokine Profile in Pediatric SLE Patients No drug interventions supportive_care Not Available completed NCT06294236
Study Evaluating SC291 in Subjects With Severe r/r B-cell Mediated Autoimmune Diseases (GLEAM) treatment 1 recruiting NCT00637819
Leflunomide in Systemic Lupus Erythematosus treatment 2 completed NCT05688696
Evaluate the Efficacy and Safety of Orelabrutinib in Adult Patients With Systemic Lupus Erythematosus treatment 2 recruiting NCT04461158
CCCR Lupus Patient Navigator Program No drug interventions supportive_care Not Available completed NCT02782039
Register of Patients With Anti-Phospholipids Syndrome (APS) and/or Systemic Lupus Erythematosus (SLE) No drug interventions Not Available Not Available unknown_status NCT05458622
3TR (Taxonomy, Treatment, Targets and Remission) Systemic Lupus Erithematosus Study Protocol No drug interventions supportive_care 3 recruiting NCT04645225
Clinical Characteristic and MEFV Gene Mutations in Patient With Juvenile Onest Systemic Lupus Erythematosus No drug interventions Not Available Not Available unknown_status NCT01992666
GENetic & Immunologic Abnomalies in Systemic Lupus Erythematosus No drug interventions other Not Available completed NCT06548620
A Study of RD06-04 in Patients With Active Autoimmune Diseases No drug interventions treatment 0 not_yet_recruiting NCT06314282
INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use No drug interventions Not Available Not Available not_yet_recruiting NCT03030976
A Study of CD19 Redirected Autologous T Cells for CD19 Positive Systemic Lupus Erythematosus (SLE) treatment 1 unknown_status NCT00960362
An Investigation of AGS-009 in Patients With Systemic Lupus Erythematosus (SLE) No drug interventions treatment 1 completed NCT06462144
IMPT-514 in Systemic Lupus Erythematosus, Anca-associated Vasculitis, and Idiopathic Inflammatory Myopathy No drug interventions treatment 0 recruiting NCT05724940
Comparison of Clinical and Serological Differences Among Juvenile, Adult, and Late-onset Systemic Lupus Erythematosus No drug interventions Not Available Not Available not_yet_recruiting NCT04451772
A Study of the Safety of Oral Elsubrutinib Capsules and Oral Upadacitinib Tablets Given Alone or in Combination (ABBV-599) for Adult Participants With Moderately to Severely Active Systemic Lupus Erythematosus to Assess Change in Disease State treatment 2 completed NCT06010472
An Exploratory Clinical Study of Anti-CD19 CAR NK Cells in the Treatment of Systemic Lupus Erythematosus treatment 0 recruiting NCT06063668
Autotaxin as Abiomarker in Systemic Lupus Erythematosus Patients No drug interventions Not Available Not Available not_yet_recruiting NCT06144710
SG301-SC Injection Safety Study in Subjects With Systemic Lupus Erythematosus No drug interventions treatment 1 recruiting NCT06373081
Anti-CD19-CD3E-CAR-T Cells in Relapsed/Refractory Autoimmune Disease No drug interventions treatment Not Available recruiting NCT06585514
Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory Systemic Lupus Erythematosus No drug interventions treatment 1 / 2 not_yet_recruiting NCT06249438
A Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy No drug interventions treatment 1 recruiting NCT06056921
Safety and Efficacy of CD19 Targeted CAR-T Therapy for Refractory Autoimmune Disease No drug interventions treatment 1 recruiting NCT02006784
Pilot Study to Assess Flares Following Inactivated Influenza Vaccine in Children With Systemic Lupus Erythematosus (SLE) No drug interventions Not Available Not Available completed NCT05984251
A Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of CCX168 in Healthy Participants basic_science 1 completed NCT04726553
Nature of Anifrolumab Impact on Vaccine-Emergent Immunity in SLE treatment 0 recruiting NCT02779153
Acthar SLE (Systemic Lupus Erythematosus) treatment 4 withdrawn NCT05859997
Universal CAR-T Cells (BRL-301) in Relapse or Refractory Autoimmune Diseases No drug interventions treatment Not Available recruiting NCT03975361
Autoreactivity Threshold Analysis in Lupus and Immune Thrombocytopenia (Checkpoints ITP and SLE) No drug interventions basic_science Not Available unknown_status NCT04058028
Efficacy and Safety of AMG 570 in Subjects With Active Systemic Lupus Erythematosus (SLE) treatment 2 completed NCT03626311
Omega-3 Replacement With Krill Oil in Disease Management of SLE No drug interventions supportive_care Not Available completed NCT06548607
Clinical Study on Targeted CD19 CAR-T Therapy for Autoimmune Diseases No drug interventions treatment 0 recruiting NCT04702256
Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF treatment 3 recruiting NCT05624437
BElimumab corticoSteroids Sparing Treatment in Systemic Lupus Erythematosus No drug interventions Not Available Not Available completed NCT05934149
Lupus Landmark Study: A Prospective Registry and Biorepository No drug interventions Not Available Not Available recruiting NCT05352919
A Study to Evaluate the Continuous Safety and Efficacy of Litifilimab (BIIB059) in Adults With Active Systemic Lupus Erythematosus treatment 3 enrolling_by_invitation NCT02829541
A Phase 1, Single-Ascending-Dose, Safety, Tolerability, Pharmacokinetic(PK), and Pharmacodynamic(PD) Study of BIIB068 in Healthy Participants treatment 1 completed NCT01072734
Auto-immunity in Lupus Patients After Influenza Vaccine No drug interventions treatment 2 completed NCT05140824
A Study to Evaluate the Safety, Tolerability, and PK Profile of Single and Multiple Doses TJ202 in Patient With Systemic Lupus Erythematosus treatment 1 terminated NCT05000216
COVID-19 Booster Vaccine in Autoimmune Disease Non-Responders prevention 2 completed NCT05988216
Universal CAR-T Cells (BRL-301) in Refractory Systemic Lupus Erythematosus No drug interventions treatment Not Available recruiting NCT05411016
A Study of KK4277 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus and Cutaneous Lupus Erythematosus No drug interventions treatment 1 recruiting NCT02804763
A Phase 2 Efficacy and Safety Study of Dapirolizumab Pegol (DZP) in Systemic Lupus Erythematosus treatment 2 completed NCT03031925
Detection of Annexin A2 in Systemic Lupus Erythematosus No drug interventions basic_science Not Available completed NCT06038474
Descartes-08 for Patients With Systemic Lupus Erythematosus No drug interventions treatment 2 recruiting NCT03978520
A Study to Investigate the Safety and Efficacy of Elsubrutinib and Upadacitinib Given Alone or in Combination in Participants With Moderately to Severely Active Systemic Lupus Erythematosus (SLE) treatment 2 completed NCT03122431
Relevance of Monitoring Blood and Salivar Levels of Drugs Used in Rheumatic Autoimmune Diseases treatment 4 completed NCT00608127
Study to Evaluate the Safety, Tolerability and Short Term Efficacy of Extracorporeal Specific Immunoadsorption LupusorbTM Columns for the Treatment of Systemic Lupus Erythematosus (SLE) Patients No drug interventions treatment Not Available unknown_status NCT02811094
LUMIER² Study : LUpus Molecular Immunomonitoring to Evaluate the Risk of Relapse No drug interventions other Not Available terminated NCT00779194
Prospective Study of Rapamycin for the Treatment of SLE treatment 2 completed NCT03656562
Study the Efficacy and Safety of VAY736 and CFZ533 in SLE Patients treatment 2 active_not_recruiting NCT01151644
Safety and Efficacy of Anti-Pandemic H1N1 Vaccination in Rheumatic Diseases No drug interventions prevention 4 unknown_status NCT01753401
Acthar for the Treatment of Systemic Lupus Erythematosus (SLE) in Patients With a History of Persistently Active Disease treatment 4 completed NCT00582881
Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus No drug interventions Not Available Not Available recruiting NCT03492255
CYCLONES - CYClophosphamide LOw Dose and No Extra Steroid treatment Not Available terminated NCT06032923
Double-blind Placebo Controlled Study to Evaluate the Effect of NAD+ Boosting With Nicotinamide Riboside on Immunometabolism and Immunity in Systemic Lupus Erythematosus No drug interventions treatment 1 / 2 recruiting NCT03919643
BAFF and APRIL and RESPONSE TO BELIMUMAB in SLE No drug interventions Not Available Not Available unknown_status NCT00774943
A Study of AMG 557 in Adults With Systemic Lupus Erythematosus No drug interventions treatment 1 completed NCT00985803
Physical Activity in Patients With Systemic Lupus Erythematosus No drug interventions treatment 1 unknown_status NCT01534403
Open Label Extension Study of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) Subjects treatment 2 completed NCT03878303
Study of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE) No drug interventions treatment 1 unknown_status NCT05247203
Telitacicept Study in Chinese Subjects With Systemic Lupus Erythematosus treatment 1 completed NCT03171103
Systemic Lupus and Adverse Pregnancy Outcome No drug interventions Not Available Not Available unknown_status NCT05392790
Progressive Resisted Exercise Plus Aerobic Exercise on Osteoporotic Systemic Lupus Erythmatosus treatment Not Available recruiting NCT06340490
A Study of RJMty19 in Refractory Systemic Lupus Erythematosus (SLE) treatment 1 not_yet_recruiting NCT04971590
Study to Assess Demographic, Pharmacologic, Biomarker, Clinical Features and Quality of Life (QoL) of Participants With Lupus Nephritis No drug interventions Not Available Not Available recruiting NCT03541564
An Investigational Study of Experimental Medication BMS-986165 in Healthy Participants to Study Electrocardiogram Effects treatment 1 completed NCT03616964
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE-BRAVE II) treatment 3 completed NCT00420121
European Society of Cutaneous Lupus Erythematosus (EUSCLE) No drug interventions Not Available Not Available unknown_status NCT05132621
The Genital Tract Microflora in Women With Systemic Lupus Erythematosus (SLE) and Immunoglobulin A (IgA) Nephropathy. No drug interventions Not Available Not Available unknown_status NCT03178721
Regulatory BCells in Systemic Lupus Erythematosus No drug interventions Not Available Not Available unknown_status NCT01127321
A Safety and Tolerability Study of MEDI-570 in Systemic Lupus Erythematosus No drug interventions treatment 1 terminated NCT02953821
Acthar Gel for Active Systemic Lupus Erythematosus (SLE) treatment 4 completed NCT05638802
A Study of DS-7011a in Patients With Systemic Lupus Erythematosus No drug interventions treatment 1 / 2 recruiting NCT01101802
Mycophenolate Mofetil in Systemic Lupus Erythematosus (MISSILE) treatment 4 completed NCT01257802
GnRH-a for Ovarian Protection During CYC Therapy for Rheumatic Diseases treatment 3 terminated NCT00522002
CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study No drug interventions Not Available Not Available completed NCT00544102
Insulin Resistance and Atherosclerosis in Women With Lupus No drug interventions Not Available Not Available completed NCT00731302
Aspirin Resistance in Systemic Lupus Erythematosus (SLE) other 1 completed NCT00410384
A Study of Belimumab in Subjects With Systemic Lupus Erythematosus treatment 3 completed NCT03941184
Spontaneous Coronary Artery Dissection (SCAD) and Autoimmunity No drug interventions Not Available Not Available completed NCT02284984
Synergetic B-cell Immodulation in SLE treatment 2 completed NCT00858884
Libman-Sacks Endocarditis as a Cause of Neuropsychiatric Systemic Lupus Erythematosus No drug interventions diagnostic Not Available withdrawn NCT00297284
Memory and Attention Problems in Lupus: New Treatment Trial With Modafinil treatment Not Available terminated NCT05030779
A Study of CD19/BCMA Chimeric Antigen Receptor T Cells Therapy for Patients With Refractory Systemic Lupus Erythematosus No drug interventions treatment 0 unknown_status NCT01058343
Safety of IFNa Kinoid in Systemic Lupus Erythematosus No drug interventions treatment 1 / 2 completed NCT00071487
Safety and Efficacy Study of LymphoStat-B (Belimumab) in Subjects With Systemic Lupus Erythematosus (SLE) treatment 2 completed NCT03252587
An Investigational Study to Evaluate BMS-986165 in Participants With Systemic Lupus Erythematosus treatment 2 completed NCT05504187
Study to Evaluate Safety, Tolerability and Pharmacodynamics of KP104 in Participants With Thrombotic Microangiopathy Secondary to Systemic Lupus Erythematosus treatment 2 not_yet_recruiting NCT02653287
Lupus Intervention for Fatigue Trial No drug interventions treatment Not Available recruiting NCT00712933
A Continuation Trial for Subjects With Lupus That Completed Protocol HGS1006-C1056 or HGS1006-C1057 treatment 3 completed NCT05506033
Optimization of Glucocorticoid Taper Strategies for SLE-ITP No drug interventions treatment Not Available enrolling_by_invitation NCT00519454
Estrogen and Gender Biased Autoimmunity No drug interventions Not Available Not Available unknown_status NCT00979654
A Study to Evaluate the Long-Term Safety of MEDI-545 in Adult Participants With Systemic Lupus Erythematosus or Myositis treatment 2 completed NCT05818254
The HOP-STEP Intervention: Improving Maternal Health in Women With Lupus sIRB No drug interventions health_services_research Not Available not_yet_recruiting NCT00432354
An Open Labeled Pilot Study of Atorvastatin in Systemic Lupus Erythematosus treatment 2 / 3 unknown_status NCT03488654
CMR-Lupus Comprehensive Approach by Cardiovascular Magnetic Resonance Tomography No drug interventions Not Available Not Available terminated NCT00624351
Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus (SLE) Patients With Active Disease treatment 2 completed NCT03371251
Study of BOS161721 in Systemic Lupus Erythematosus (SLE) Patients on a Background of Limited Standard of Care treatment 1 / 2 completed NCT06137053
Effect of Telitacicept on Transitional Regulatory B Cells in Patients With Systemic Lupus Erythematosus No drug interventions Not Available Not Available recruiting NCT00493753
Feasibility and Safety of Acupuncture for Systemic Lupus No drug interventions Not Available Not Available completed NCT04449653
Mobile Study to Measure and Predict Lupus Disease Activity Using Digital Signals No drug interventions Not Available Not Available unknown_status NCT00430677
Efficacy and Safety Study of Abatacept to Treat Lupus Nephritis treatment 2 / 3 terminated NCT01705977
Belimumab Assessment of Safety in SLE treatment 4 completed NCT04335747
COVID-19 Infection in Vulnerable Patients With Inflammatory Rheumatic Diseases No drug interventions Not Available Not Available terminated NCT00671047
The Systemic Lupus Erythematosus (SLE) Activity Gene Expression (SAGE) Study No drug interventions Not Available Not Available unknown_status NCT05828147
Anti-CD20 Antibodies for Treatment of SLE-PAH treatment 4 recruiting NCT06465147
REACT-01: Reversing Autoimmunity Through Cell Therapy No drug interventions treatment 1 not_yet_recruiting NCT05381545
Laser Puncture and Program of Lifestyle Modification in Lupus Females No drug interventions treatment Not Available unknown_status NCT02504645
A 52-Week, Randomized, Double-Blind, Parallel-Group, Placebo-Controlled Study to Evaluate the Efficacy and Safety of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus treatment 3 completed NCT01395745
CHABLIS-SC1: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus treatment 3 completed NCT05971498
Assessment of Anxiety, Depression, Sleep Quality and Quality of Life in Systemic Lupus Erythematosus Patients No drug interventions Not Available Not Available recruiting NCT00181298
Memantine in Systemic Lupus Erythematosus treatment Not Available completed NCT06581198
A Study of Rapcabtagene Autoleucel in Systemic Lupus Erythematosus (SLE) Patients With Active, Refractory Lupus Nephritis (LN) No drug interventions treatment 2 recruiting NCT02124798
A Phase 2B Open-Label, Single-Arm, Repeat-Dose Study to Evaluate the Reliability of an Autoinjector No drug interventions other 2 completed NCT02631005
Walk With Ease Program For Patients With Systemic Lupus Erythematosus No drug interventions treatment Not Available completed NCT00626197
A Study to Evaluate Ocrelizumab in Patients With Nephritis Due to Systemic Lupus Erythematosus (BELONG) treatment 3 terminated NCT02106897
Study Evaluating the Safety, Tolerability, and Pharmacokinetics of Single Doses and Multiple Doses of BIIB059 (Litifilimab) in Healthy Volunteers and Participants With Systemic Lupus Erythematosus treatment 1 completed NCT03917797
Mesenchymal Stromal Cells (MSC´s) in Renal Lupus No drug interventions treatment 2 recruiting NCT06121297
RESET-SLE: A Phase 1/2 Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Systemic Lupus Erythematosus No drug interventions treatment 1 / 2 recruiting NCT04835883
Exploring the Efficacy and Safety of CS20AT04 (Allogenic Bone Marrow-Derived Stem Cell) in Systemic Lupus Erythematosus Patients No drug interventions treatment 2 recruiting NCT03161483
A Study to Evaluate the Efficacy and Safety of CC-220 in Subjects With Active Systemic Lupus Erythematosus treatment 2 completed NCT04776161
Medication Adherence Patterns in Rheumatic Diseases: A Behavioral Trial No drug interventions health_services_research Not Available completed NCT00413361
The Reduction of Systemic Lupus Erythematosus Flares :Study PLUS prevention 4 completed NCT04893161
A Model About the Response of Belimumab in SLE treatment 4 not_yet_recruiting NCT04530461
Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases No drug interventions Not Available Not Available unknown_status NCT02537028
MSC2364447C Phase 1b in Systemic Lupus Erythematosus treatment 1 completed NCT00037128
Study of GL701 in Men With Systemic Lupus Erythematosus No drug interventions treatment 3 unknown_status NCT06255028
A Study of CNTY-101 in Participants With Refractory B Cell-mediated Autoimmune Diseases (CALiPSO-1) No drug interventions treatment 1 recruiting NCT05087628
PRV-3279-2a Trial in Systemic Lupus No drug interventions treatment 2 active_not_recruiting NCT06413511
A Study to Investigate the Safety and Pharmacological Effect of a Single Intravenous Infusion of Belantamab in Male and Female Participants Aged 18 to 75 With Moderate to Severe Systemic Lupus Erythematosus No drug interventions treatment 1 recruiting NCT02066311
Nelfinavir in Systemic Lupus Erythematosus treatment 2 terminated NCT05845593
Relationship Between Data Obtained With the LuGENE® Multiparameter Transcriptomics Blood Test and Clinical and Standard Laboratory Features of Patients With SLE (ReLATE) No drug interventions Not Available Not Available recruiting NCT01261793
Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus (SLE) treatment 3 completed NCT00588393
FolateScan in Autoimmune Disease No drug interventions diagnostic 2 completed NCT03396393
Exploratory Study of DHA in Systemic Lupus Erythematosus Patients treatment 2 unknown_status NCT00392093
Effect of Hormone Replacement Therapy on Lupus Activity treatment 4 completed NCT01753193
An Open-label Study to Evaluate the Long-term Safety of MEDI-546, for the Treatment of SLE, in Adults treatment 2 completed NCT04275193
The Safety and Efficacy of Zishenqing in Subjects With Active Systemic Lupus Erythematosus No drug interventions treatment 2 / 3 unknown_status NCT06576271
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants and Healthy Chinese and Japanese Participants treatment 1 not_yet_recruiting NCT03937271
Objective Measurement Methods for Autoimmune Disease and Dry Eye Syndrome No drug interventions Not Available Not Available withdrawn NCT05559671
Safety of the Herpes Zoster Subunit Vaccine in Lupus treatment 4 recruiting NCT01449071
Study Evaluating the Pharmacokinetics and Safety of Epratuzumab in Japanese Systemic Lupus Erythematosus (SLE) treatment 1 / 2 completed NCT00723671
Magnetic Resonance Spectroscopy, Perfusion and Diffusion Tensor Imaging in Neuropsychiatric Lupus No drug interventions diagnostic Not Available completed NCT05693571
Engagement in CHildhood-Onset Systemic Lupus No drug interventions prevention Not Available recruiting NCT00750971
Autologous Stem Cell Transplantation for Refractory Systemic Lupus Erythematosus (ASSIST) No drug interventions treatment 2 unknown_status NCT02408471
Ascension® Post- Approval Study; PyroCarbon Metacarpophalangeal Total Joint Prosthesis No drug interventions treatment Not Available terminated NCT00113971
Pharmacokinetics Study of Epratuzumab in Systemic Lupus Erythematosus (SLE) treatment 2 terminated NCT02070978
Long-term Safety and Tolerability of Atacicept (Long-term Follow-Up of Participant Who Participated in ADDRESS II) treatment 2 terminated NCT06308978
FT819 in Moderate to Severe Active Systemic Lupus Erythematosus treatment 1 recruiting NCT03802578
The Impact of Exercise on Hand Function, Daily Activities Performance and Quality of Life of SLE' Patients No drug interventions supportive_care Not Available completed NCT00828178
Efficacy of Fish Oil in Lupus Patients treatment 4 completed NCT05799378
Effects of Stopping Hydroxychloroquine in Elderly Lupus Disease treatment 3 recruiting NCT00119678
Abatacept in the Treatment and Prevention of Active Systemic Lupus Erythematosus (SLE) Flares in Combination With Prednisone prevention 2 completed NCT03802188
Hydroxychloroquine in Systemic Lupus Erythematosus No drug interventions Not Available Not Available recruiting NCT05917288
A Study of Belimumab in Chinese Pediatric Participants With Systemic Lupus Erythematosus treatment 1 not_yet_recruiting NCT04060888
A Study of Ustekinumab in Chinese Participants With Active Systemic Lupus Erythematosus treatment 3 withdrawn NCT06428188
Sequential CAR-T Cells Targeting BCMA/CD19 in Patients With Relapsed/ Refractory Autoimmune Diseases No drug interventions treatment 1 / 2 recruiting NCT04747288
Objective Measurement With TCM Pattern for AIDDES No drug interventions Not Available Not Available recruiting NCT02291588
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AMG 811 in Subjects With Systemic Lupus Erythematosus No drug interventions treatment 1 completed NCT05927688
Assessment of Physician Consideration of ePRO's, From Patients With Gout, Rheumatoid Arthritis, Sjogren's Syndrome or Systemic Lupus, on the Frequency of Therapeutic Adjustments No drug interventions Not Available Not Available recruiting NCT05465707
A Study of CM313 Injection in Subjects With Systemic Lupus Erythematosus No drug interventions treatment 1 / 2 unknown_status NCT03556007
A Study of NKTR-358 (LY3471851) in Participants With Systemic Lupus Erythematosus (SLE) basic_science 1 completed NCT03312907
A Study to Evaluate the Efficacy and Safety of Belimumab Administered in Combination With Rituximab to Adult Subjects With Systemic Lupus Erythematosus (SLE) - BLISS-BELIEVE treatment 3 completed NCT05899907
Efficacy and Safety of Telitacicept in Early SLE treatment 4 recruiting NCT02428309
Autologous Polyclonal Tregs for Lupus No drug interventions treatment 1 terminated NCT05292456
Monıtorıng Glucocortıcoıd Treatment In Patıents Followed In Rheumatology Clınıc No drug interventions Not Available Not Available unknown_status NCT03937856
Smartphone Mindfulness Meditation for Patients With Rheumatic Diseases No drug interventions treatment Not Available terminated NCT03618056
Evaluating HIV-1 Neutralization Antibody Breadth in Response to HIV gp120 Protein Vaccine in HIV-uninfected Adults With Quiescent Systemic Lupus Erythematosus No drug interventions prevention 1 completed NCT04433585
A Study of LY3471851 in Adults With Systemic Lupus Erythematosus (SLE) treatment 2 completed NCT03771885
BI 705564 in Patients With Systemic Lupus Erythematosus (SLE) No drug interventions treatment 1 withdrawn NCT01170585
A Trial of Rosuvastatin in Systemic Lupus Erythematosus treatment 2 completed NCT04839315
COVID-19 Vaccination in Rheumatic Disease Patients No drug interventions health_services_research 0 terminated NCT01112215
Enteric-coated Mycophenolate Sodium Versus Azathioprine for the Extra-renal Lupus Manifestations treatment 4 completed NCT04453215
Laser Therapy for Patients With Systemic Lupus Erythematosus No drug interventions treatment Not Available completed NCT02725515
A Study of the Effect of XmAb®5871 in Patients With Systemic Lupus Erythematosus treatment 2 completed NCT03742037
Efficacy and Safety of Four Doses of Cenerimod Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus treatment 2 completed NCT06400537
Clinical Study of A-319 in the Treatment of Active/Refractory Systemic Lupus Erythematosus No drug interventions treatment 1 recruiting NCT04397237
Prevalence and Seroconversion of COVID-19 in Autoimmune Diseases in Europe No drug interventions Not Available Not Available unknown_status NCT04179032
Study of Subcutaneous (SC) Belimumab in Pediatric Participants With Systemic Lupus Erythematosus (SLE) treatment 2 active_not_recruiting NCT00155532
Skin Denervation in Systemic Lupus Erythematosus No drug interventions diagnostic 1 completed NCT05900232
Anti KU Antibodies and Its Relationship With Systemic Lupus Erythematosus No drug interventions screening Not Available recruiting NCT02880852
Belimumab Phase I Study in Chinese Subjects With Systemic Lupus Erythematosus treatment 1 completed NCT00774852
Abatacept and Cyclophosphamide Combination Therapy for Lupus Nephritis treatment 2 completed NCT01120652
Reducing Depressive Symptoms in Systemic Lupus Erythematosus No drug interventions treatment Not Available completed NCT06429800
A Study to Evaluate the Safety and Preliminary Efficacy of ATA3219 in Participants with Systemic Lupus Erythematosus No drug interventions treatment 1 not_yet_recruiting NCT00997100
Exploratory Study of Changes in Disease Activity and Biomarkers With ABR-215757 in Patients With Mild Active Systemic Lupus Erythematosus (SLE) basic_science 2 completed NCT00976300
Cyclosporine A or Intravenous Cyclophosphamide for Lupus Nephritis: The Cyclofa-Lune Study treatment 2 completed NCT00010400
Pilot Study of Cyclophosphamide in Patients With Life-Threatening Systemic Lupus Erythematosus or Antiphospholipid Antibody Syndrome treatment Not Available completed NCT05648500
A Research Study to Evaluate the Effects of a New Oral Medicine Called Cenerimod in Adults With Systemic Lupus Erythematosus treatment 3 recruiting NCT04345159
Association Between Long-term Hydroxychloroquine Treatment and Outcome of a History of Symptoms Suggestive of COVID-19 Infection During the Epidemic Period in France in Patients With Autoimmune Disease No drug interventions Not Available Not Available completed NCT03747159
Synergetic B-cell Immunomodulation in SLE - 2nd Study. treatment 3 recruiting NCT03951259
Safety and Efficacy of SM934 Compared to Placebo in Adult Subjects With Active Systemic Lupus Erythematosus No drug interventions treatment 2 completed NCT00071175
Lupus Genetics Studies No drug interventions Not Available Not Available completed NCT03189875
Systemic Lupus Erythematosus (SLE) Prospective Observational Cohort Study (SPOCS) No drug interventions Not Available Not Available completed NCT00004375
Ultraviolet Light Therapy for Systemic Lupus Erythematosus No drug interventions treatment 2 unknown_status NCT01425775
The Effect of Vitamin D Supplementation on Disease Activity Markers in Systemic Lupus Erythematosus (SLE) treatment Not Available completed NCT01541670
Safety Study of Anti-Macrophage Migration Inhibitory Factor (Anti-MIF) Antibody in Lupus Nephritis No drug interventions treatment 1 terminated NCT06308770
Fatigue in Lupus Intervention Programmes (FLIP) No drug interventions treatment Not Available recruiting NCT05115370
Vaccination Perception in Inflammatory Conditions - Flu, Pneumonia and COVID-19 No drug interventions Not Available Not Available completed NCT00982670
A Study of the Metabolic Syndrome in Patients With Systemic Lupus Erythematosus No drug interventions Not Available Not Available completed NCT02270970
Evaluation of Belimumab Impact on a BLyS Activity Signature Test in the Absence of Confounding Polypharmacy treatment 4 unknown_status NCT01914770
Effectiveness of Belimumab Treatment in a Subpopulation of Systemic Lupus Erythematosus (SLE) Patients: a Pooled Analysis of BLISS-52 and BLISS-76 Not Available Not Available completed NCT06475742
Long-term Safety and Tolerability of Cenerimod in Adults With Systemic Lupus Erythematosus treatment 3 enrolling_by_invitation NCT00069342
Health Beliefs and Health Behaviors Among Minorities With Rheumatic Diseases No drug interventions Not Available Not Available completed NCT05796206
A Clinical Study of MIL62 in Systemic Lupus Erythematosus No drug interventions treatment 2 / 3 recruiting NCT00111306
Study of Epratuzumab in Systemic Lupus Erythematosus treatment 3 terminated NCT06001606
Immunogenicity, Reactogenicity of Shingrix in SLE treatment 3 recruiting NCT01988506
Induction of Regulatory t Cells by Low Dose il2 in Autoimmune and Inflammatory Diseases No drug interventions treatment 2 completed NCT00065806
Atherosclerosis Prevention in Pediatric Lupus Erythematosus (APPLE) treatment 3 completed NCT06106906
A Clinical Study of CD19 CAR-T in Active Systemic Lupus Erythematosus No drug interventions treatment 1 / 2 recruiting NCT05765006
CD19-CART(Relma-cel) for Moderate to Severe Active Systemic Lupus Erythematosus treatment 1 recruiting NCT01642706
Regulatory B Cells in Inflammatory Rheumatisms and Biomarkers of Response to Biologic Treatments No drug interventions Not Available Not Available unknown_status NCT05624749
Phase 3 Study to Evaluate Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 2) treatment 3 recruiting NCT00008749
Role of Altered CD40-Ligand Gene Transcription in Systemic Lupus Erythematosus No drug interventions Not Available Not Available unknown_status NCT06530849
A Study of GC012F Injection in Subjects With Refractory Systemic Lupus Erythematosus No drug interventions treatment 1 / 2 not_yet_recruiting NCT06411249
A Study Describing the Efficacy and Safety of Belimumab Administered in Adult Participants With Early Systemic Lupus Erythematosus (SLE) treatment 4 recruiting NCT00541749
A Study of rhuMAb IFNalpha in Adults With Systemic Lupus Erythematosus No drug interventions treatment 1 completed NCT03159936
Oral Tofacitinib in Adult Subjects With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) treatment 0 terminated NCT05666336
Multi-omics Studies on the Efficacy of Telitacicept in Chinese SLE Patients treatment 4 recruiting NCT00005436
Lupus Cohort--Thrombotic Events and Coronary Artery Disease No drug interventions Not Available Not Available completed NCT02975336
A Phase II Study of M2951 in SLE treatment 2 terminated NCT01031836
A Study to Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545 in Patients With Systemic Lupus Erythematosus. treatment 2 completed NCT03393013
A Study of KZR-616 in Patients With SLE With and Without Lupus Nephritis treatment 1 / 2 completed NCT02281513
Activity and Nutrition Trial in Lupus to Energize and Renew No drug interventions prevention Not Available completed NCT05879718
A Study to Learn About the Study Medicine (PF-06823859) in Adults With Active CLE or SLE With Skin Symptoms. treatment 2 recruiting NCT03030118
Study of Anti-Malarials in Incomplete Lupus Erythematosus prevention 2 active_not_recruiting NCT03248518
Lessening the Impact of Fatigue in Inflammatory Rheumatic Diseases No drug interventions treatment Not Available completed NCT03942718
Systemic Lupus Erythematosus Exercise Program No drug interventions treatment Not Available completed NCT00025818
Six Month Clinical Research Study for Patients With Moderate or Severe Dry Eye Syndrome treatment 3 completed NCT05478018
Type 1 Interferon Induced Changes to Exercise Adaptations in Systemic Lupus Erythematosus Patients No drug interventions basic_science Not Available active_not_recruiting NCT03374618
Neutrophil Extracellular Traps in Systemic Sclerosis No drug interventions basic_science Not Available completed NCT06347718
CAR-T Cells in Systemic B Cell Mediated Autoimmune Disease No drug interventions treatment 1 / 2 recruiting NCT02554019
Proof-of-Concept Study With BT063 in Subjects With Systemic Lupus Erythematosus No drug interventions treatment 2 completed NCT05203419
Multiple Ascending Dose Study of MHS552 in Adults Participants With Systemic Lupus Erythematosus (SLE) No drug interventions treatment 1 terminated NCT05326841
Effect of Cholecalciferol Supplementation on Disease Activity and Quality of Life of Systemic Lupus Erythematosus Patients . treatment 3 completed NCT00401141
Abnormalities of B Lymphocytes During Systemic Lupus No drug interventions Not Available Not Available completed NCT01632241
Efficacy and Safety of Belimumab in Black Race Patients With Systemic Lupus Erythematosus (SLE) treatment 4 completed NCT01863641
The Effect of Calcitriol on Progress and Activity of Lupus Nephritis treatment 2 unknown_status NCT03138941
Validation of the Lupus Low Disease Activity State (LLDAS) in the Asia Pacific Region No drug interventions Not Available Not Available recruiting NCT04532541
Monogenic Lupus in Childhood Onset Systemic Lupus Erythematosus No drug interventions Not Available Not Available recruiting NCT01164917
Safety Study of AMG 811 in Subjects With Discoid Lupus Erythematosus No drug interventions treatment 1 terminated NCT05105217
Evaluation of Slit2 in Systemic Lupus Erythematosus and Systemic Sclerosis Patients No drug interventions Not Available Not Available unknown_status NCT00000417
Psychoeducational Approach to Improve Health in Lupus No drug interventions treatment 2 completed NCT02558517
Evaluation of the Discontinuation of Maintenance Corticosteroid Treatment in Quiescent Systemic Lupus treatment 3 unknown_status NCT05339217
Efficacy and Immunological Evaluation of Telitacicept and Low Dose IL2 in the Treatment of Systemic Lupus Erythematosus treatment 3 recruiting NCT04361734
The Role of Lipids in Immune Cell Function in SLE Patients No drug interventions Not Available Not Available unknown_status NCT06046534
Retrospective Medical Chart Review Study to Describe the Experience of SLE Patients Treated With Anifrolumab in the Early Access Programs. No drug interventions Not Available Not Available completed NCT03938324
Peer i-Coaching for Activated Self-Management Optimization in Adolescents and Young Adults With Chronic Conditions No drug interventions supportive_care Not Available completed NCT06327724
Belimumab in SLE Synovial Inflammation and Lymph Nodes Not Available Not Available recruiting NCT06226324
fMRI Study of Early Brain Injury in Systemic Lupus Erythematosus No drug interventions Not Available Not Available recruiting NCT03288324
Open-label Study of Tofacitinib for Moderate to Severe Skin Involvement in Young Adults With Lupus treatment 1 / 2 completed NCT02920424
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-56022473 in Subjects With Systemic Lupus Erythematosus treatment 1 withdrawn NCT00714116
Study Evaluating The SBI-087 In Subjects With Systemic Lupus Erythematosus No drug interventions treatment 1 completed NCT00000416
Prevention of Arthritis-Related Work Disability No drug interventions prevention Not Available completed NCT06161116
Efficacy And Safety Of MK-6194 In Adult Participants With Systemic Lupus Erythematosus (MK-6194-006) No drug interventions treatment 2 recruiting NCT03724916
A Study to Evaluate the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of TAK-079 in Combination With Standard Background Therapy in Participants With Moderate to Severe Systemic Lupus Erythematosus (SLE) other 1 completed NCT04963296
A Study to Evaluate the Efficacy and Safety of Obinutuzumab in Participants With Systemic Lupus Erythematosus treatment 3 recruiting NCT01484496
A Study of Belimumab Administered Subcutaneously in Subjects With Systemic Lupus Erythematosus (SLE) treatment 3 completed NCT04184258
Treatment of Systemic Lupus Erythematosus With Pooled Allogenic Mesenchymal Stem Cells No drug interventions treatment 1 / 2 completed NCT02525835
Tissue Sodium in Autoimmune Disease No drug interventions treatment Not Available withdrawn NCT06029335
Clinical Risk Assessment of Cognitive Function in Systemic Autoimmune Diseases No drug interventions Not Available Not Available active_not_recruiting NCT06394063
Efficacy and Safety of Telitacicept for Prevention of Flares in SLE Patients prevention Not Available recruiting NCT06119763
AntiDFS70 Lupus Nephritis No drug interventions Not Available Not Available recruiting NCT03370263
BENLYSTA® Special Drug Use Investigation Not Available Not Available recruiting NCT01515163
Exercise and Systemic Lupus Erythematosus No drug interventions treatment Not Available unknown_status NCT05262686
Efficacy and Immunological Evaluation of Belimumab Plus Low Dose IL-2 in the Treatment of Systemic Lupus Erythematosus treatment 3 unknown_status NCT05835986
A First-in-Human Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of RO7507062 in Participants With Systemic Lupus Erythematosus treatment 1 recruiting NCT05315739
Vagus Nerve Stimulation for Systemic Lupus Erythematous No drug interventions treatment Not Available unknown_status NCT01283139
A Study to Evaluate the Efficacy and Safety of Sifalimumab in Adults With Systemic Lupus Erythematosus treatment 2 completed NCT03933839
Internet-Based Pain Coping Skills Training for Patients With Lupus No drug interventions treatment Not Available completed NCT04873739
AS-OCT Study of Cornea and Tear Film Parameters in SLE Patients No drug interventions Not Available Not Available completed NCT00479622
Study of TRU-015 in Subjects With Membranous Nephropathy Secondary to Systemic Lupus Erythematosus treatment 1 terminated NCT04976322
A Study to Evaluate the Safety and Tolerability of Dapirolizumab Pegol in Study Participants With Systemic Lupus Erythematosus treatment 3 enrolling_by_invitation NCT03451422
Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Efavaleukin Alfa in Participants With Systemic Lupus Erythematosus basic_science 1 completed NCT01597622
BEL114333, a Continuation Study of BEL113750 in Subjects With Systemic Lupus Erythematosus (SLE) in Northeast Asia, and in Japan Subjects Completing the Open-label Extension of HGS1006-C1115 treatment 3 completed NCT05440422
The Role of Anifrolumab in Improving Markers of Vascular Risk in Patients With Systemic Lupus Erythematosus (SLE) - IFN-CVD treatment 2 recruiting NCT00668330
Steroid Induced Osteoporosis in Patients With Systemic Lupus Erythematosus treatment 4 completed NCT05714930
LUPUS-BEST - Treat-to-target in Systemic Lupus Erythematosus No drug interventions treatment Not Available recruiting NCT06544330
Autologous CD19 CAR-T Cell Therapy (SYNCAR-001) + Orthogonal IL-2 (STK-009) in Subjects With Severe, Refractory Systemic Lupus Erythematosus No drug interventions treatment 1 not_yet_recruiting NCT04799730
Expression of CXCR4 in Patients With Systemic Lupus Erythematosus No drug interventions Not Available Not Available unknown_status NCT06015230
Clinical Study to Investigate the Safety, Tolerability, and Pharmacokinetics of GR1603 in SLE No drug interventions treatment 1 / 2 recruiting NCT01892748
Cholecalciferol Supplementation on Disease Activity, Fatigue and Bone Mass on Juvenile Systemic Lupus Erythematosus. treatment Not Available completed NCT03204448
Clinical Performance of BioCLIA Ro60 No drug interventions Not Available Not Available withdrawn NCT05856448
A Study Evaluating the Effects of GLPG3667 Administered as Oral Treatment in Adult Participants With Active Systemic Lupus Erythematosus No drug interventions treatment 2 recruiting NCT05929248
Exploring the Therapeutic Effect of Telitacicept on Lupus Erythematosus Complicated With Thrombocytopenia treatment 2 not_yet_recruiting NCT05544448
In Vitro Effect Study of Interleukin-2 Muteins on Regulatory T Cells of Patients With Different Autoimmune, Allo-immune or Inflammatory Diseases No drug interventions basic_science Not Available unknown_status NCT06339957
Rheumatology Diet Study No drug interventions Not Available Not Available recruiting NCT05433857
Probiotics in Systemic Lupus Erythematosus treatment 2 recruiting NCT01741857
Umbilical Cord Derived Mesenchymal Stem Cells Transplantation for Active and Refractory Systemic Lupus Erythematosus No drug interventions treatment 1 / 2 unknown_status NCT03738826
Reducing Disparities in Medication Adherence in SLE No drug interventions health_services_research Not Available completed NCT00172666
Decoy Receptor 3 (DcR3) Polymorphisms in Rheumatoid Arthritis (RA) and Systemic Lupus Erythematosus (SLE) No drug interventions Not Available Not Available unknown_status NCT04908865
Open-label Study of Belimumab Plus Standard Therapy in Chinese Pediatric Participants With Active Systemic Lupus Erythematosus (SLE) treatment 4 active_not_recruiting NCT04976465
Treatment and Clinical Outcomes Among SLE Patients in Pregnancy No drug interventions treatment 1 recruiting NCT06293365
Two-period Crossover Study to Demonstrate the Comparability of Pharmacokinetics of Subcutaneous Ianalumab Between 2mL Auto-injector/2mL PFS with1mL Pre-filled Syringe in Adult Participants With Autoimmune Disease basic_science 2 recruiting NCT03757065
Cell Surface Marker Expression in Autoimmune Diseases No drug interventions Not Available Not Available completed NCT01262365
Study of Epratuzumab Versus Placebo in Subjects With Moderate to Severe General Systemic Lupus Erythematosus treatment 3 completed NCT04833465
Development of a Therapeutic Endpoint in Pediatric Rheumatologic Conditions No drug interventions Not Available Not Available recruiting NCT00582465
Study to Evaluate the Natural History of Osteoporosis in Children and Adolescents With Systemic Lupus Erythematosus No drug interventions Not Available Not Available completed NCT01649765
Pediatric Lupus Trial of Belimumab Plus Background Standard Therapy treatment 2 active_not_recruiting NCT05306574
A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-1) treatment 3 recruiting NCT00046774
Monoclonal Antibody Treatment for Systemic Lupus Erythematosus No drug interventions treatment 1 completed NCT03027674
Topical 10 % Nifedipine Versus 5% Sildenafil in Secondary Raynaud treatment 0 completed NCT03459274
Feasibility of an Immersive Virtual Reality Based Biofeedback Intervention for Outpatients in Rheumatology No drug interventions Not Available Not Available unknown_status NCT00000420
Safety of Estrogens in Lupus: Birth Control Pills treatment 3 completed NCT00441220
Cyclophosphamide in Lupus Nephritis No drug interventions Not Available Not Available unknown_status NCT01276782
Levothyroxine in Pregnant SLE Patients prevention 4 withdrawn NCT00815282
Immune Response After Human Papillomavirus Vaccination in Patients With Autoimmune Disease No drug interventions diagnostic 4 completed NCT05613582
The Effectiveness of Transcranial Direct Current Stimulation as Adjunctive Treatment for Chronic Daily Headache in Systemic Lupus Erythematosus No drug interventions treatment Not Available not_yet_recruiting NCT03407482
An Extension Study of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus treatment 2 terminated NCT03165682
Fatigue, Depression, and Cortical Excitability in Systemic Lupus No drug interventions Not Available Not Available unknown_status NCT02625831
Anti-ficolin-3 Autoantibodies in Lupus Nephritis No drug interventions Not Available Not Available completed NCT00987831
Biomarkers of Lupus Disease: Serial Biomarker Sampling in Patients With Active Systemic Lupus Erythematosus (SLE) treatment 1 / 2 completed NCT01440231
Atacicept Demonstrating Dose RESponSe treatment 2 withdrawn NCT05698173
Systemic Lupus Erythematosus and Accelerated Aging No drug interventions other Not Available recruiting NCT02418273
Denosumab for Glucocorticoid-treated Children With Rheumatic Disorders treatment 1 / 2 withdrawn NCT04951427
PRediction Of Flares In Lupus With autoantibodiEs and Chemokines No drug interventions Not Available Not Available unknown_status NCT05540327
The Willow LTE Study With M5049 in Participants With SCLE, DLE and/or SLE (WILLOW LTE) treatment 2 recruiting NCT03262727
The Effect of BMS-986165 Combined With an Oral Contraceptive (Ethinyl Estradiol/Norethindrone) in Healthy Female Patients treatment 1 completed NCT03656627
Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease treatment 1 terminated NCT05672576
A Research Study to Evaluate the Efficacy and Safety of Cenerimod in Subjects Suffering From Systemic Lupus Erythematosus treatment 3 recruiting NCT03979976
Ramipril, Endothelial Function and Endothelial Progenitor Cells in Patients With Systemic Lupus Erythematosus prevention 2 / 3 completed NCT00424476
A Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) treatment 3 completed NCT00775476
Treatment of Systemic Lupus Erythematosus (SLE) With N-acetylcysteine treatment 2 recruiting NCT01408576
Open Label Extension Study of Epratuzumab in Subjects With Systemic Lupus Erythematosus treatment 3 completed NCT01894360
A Study to Estimate the Relative Bioavailability, Tolerability and Safety of a Single Dose of Belimumab Self-Administered Subcutaneously (SC) by Healthy Subjects treatment 1 completed NCT02962960
A Study to Characterize the Pharmacokinetics, Pharmacodynamics, and Safety of Anifrolumab in Adult Type I Interferon Test High Systemic Lupus Erythematosus Subject With Active Skin Manifestations treatment 2 completed NCT00512694
Duke Lupus Registry No drug interventions Not Available Not Available recruiting NCT02102594
Therapy of Antibody-mediated Autoimmune Diseases by Bortezomib (TAVAB) treatment 2 terminated NCT06449794
Neuropsycatric Disorders Among Children With Systemic Lupus Erythematosus in Sohag University Hospital No drug interventions Not Available Not Available recruiting NCT01764594
Safety Study of CDP7657 in Patients With Systemic Lupus Erythematosus Not Available 1 completed NCT01240694
A Long-Term Study of the Safety and Tolerability of Repeated Administration of CEP-33457 in Participants With Systemic Lupus Erythematosus No drug interventions treatment 3 terminated NCT02350491
Study During Pregnancy of Expression of miRNAs in RA or SLE No drug interventions Not Available Not Available completed NCT05236491
COvid-19 Vaccine Booster in Immunocompromised Rheumatic Diseases No drug interventions prevention 2 / 3 recruiting NCT02875691
Effect of Green Tea on Treatment of Lupus No drug interventions supportive_care 2 completed NCT05193591
Anti-C1s, Anti-HMGB1 and Anti-C1q Autoantibodies in Systemic Lupus Erythematosus (DYSALARM-322) No drug interventions Not Available Not Available recruiting NCT00513591
Duke Autoimmunity in Pregnancy Registry No drug interventions Not Available Not Available completed NCT02041091
A Study of Tabalumab (LY2127399) Using Two Different Injection Methods in Participants With Lupus treatment 3 terminated NCT00583362
A Continuation Trial for Subjects With Systemic Lupus Erythematosus That Have Completed Protocol LBSL02 treatment 2 completed NCT00004662
Phase III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Active Systemic Lupus Erythematosus treatment 3 completed NCT02465580
A Pilot-Study With Low-dose hrIL-2 for the Treatment of Systemic Lupus Erythematosus treatment 2 unknown_status NCT05632029
Laser Acupuncture in Egyptian Systemic Lupus Females With Insulin Resistance No drug interventions treatment Not Available recruiting NCT00866229
Efficacy and Adverse Effect of Simvastatin Compare to Rosuvastatin in Systemic Lupus Erythematosus (SLE) Patients With Corticosteroid Therapy and High Low-Density Lipoprotein (LDL) Cholesterol Level treatment 4 unknown_status NCT05261529
Effects of an Intervention With EVOO and Physical Activity in Patients With Systemic Lupus Erythematosus No drug interventions supportive_care Not Available recruiting NCT01438489
A Study of the Efficacy and Safety of MEDI-546 in Systemic Lupus Erythematosus treatment 2 completed NCT01509989
International Prospective Study on Adherence to Treatment in Patients With Active Systemic Lupus Erythematosus No drug interventions Not Available Not Available completed NCT02535689
Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosus other 1 completed NCT05347992
ELEVATE - (Empower Lupus Erythematosus Patients Via Allowing RemoTe Evaluation) No drug interventions Not Available Not Available active_not_recruiting NCT05203692
A Study of a Single Ascending Dose Study of DS-7011a in Healthy Subjects No drug interventions treatment 1 completed NCT00556192
Can Targeted Elimination of B-cell Depletion Therapy and/or Combination Therapy on Systemic Lupus Erythematosus treatment 2 completed NCT01597492
A Study to Evaluate the Effect of Belimumab on Vaccine Responses in Subjects With Systemic Lupus Erythematosus (SLE) treatment 4 completed NCT00504244
Myfortic Versus Azathioprine in Systemic Lupus Erythematosus treatment 3 terminated NCT05289544
Phone-Based Based Walk With Ease Program for Adults With Arthritis No drug interventions supportive_care Not Available active_not_recruiting NCT02530944
Web-based Genetic Research on Lupus No drug interventions Not Available Not Available completed NCT02655640
The Impact of Illness Perceptions on Health Related Outcomes in Patients With Lupus and Systemic Sclerosis No drug interventions Not Available Not Available completed NCT06356740
Efficacy and Tolerance of Abacavir/Lamivudine Treatment in Patients With Systemic Lupus Erythematosus treatment 2 not_yet_recruiting NCT00732940
Phase 2 Study of Belimumab Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus (SLE) treatment 2 terminated NCT05007340
ILD-SARDs Registry and Biorepository No drug interventions Not Available Not Available recruiting NCT02618967
Single Ascending Dose Study of AMG 570 in Healthy Subjects treatment 1 completed NCT06456567
A Study of Telitacicept for the Treatment of Moderately to Severely Active Systemic Lupus Erythematosus (REMESLE-2) treatment 3 not_yet_recruiting NCT04294667
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus treatment 3 completed NCT00371501
Aspirin and Statins for Prevention of Atherosclerosis and Arterial Thromboembolism in Systemic Lupus Erythematosus prevention 4 completed NCT04276701
Immune Mediators and Metabolites to Stratify Systemic Lupus Erythematosus Patients at High Risk of Cardio Vascular Diseases No drug interventions other Not Available recruiting NCT00089804
Study of LJP 394 in Lupus Patients With History of Renal Disease treatment 3 terminated NCT00293072
Pilot Study of Rituximab Therapy for Systemic Lupus Erythematosus (SLE) and Vasculitis treatment 2 completed NCT01616472
WEUKBRE5716: Steroid-related Damage in Systemic Lupus Erythematosus (Hopkins) No drug interventions Not Available Not Available completed NCT00001372
Study of Systemic Lupus Erythematosus No drug interventions Not Available Not Available recruiting NCT04046172
Treatment of Periodontal Disease in Systemic Lupus Erythematosus No drug interventions treatment Not Available unknown_status NCT06133972
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension). treatment 3 recruiting NCT03527472
Memantine for the Treatment of Cognitive Impairment in Systemic Lupus Erythematosus treatment 2 recruiting NCT06041568
A Study of Imvotamab in Severe Systemic Lupus Erythematosus treatment 1 recruiting NCT06518668
A Study of NKX019, a CD19 CAR NK Cell Therapy, in Subjects With Systemic Lupus Erythematosus treatment 1 recruiting NCT06462768
Neutrophil Extracellular Traps in Different Forms of Systemic Sclerosis No drug interventions Not Available Not Available recruiting NCT02456168
Development of a Novel Glutamate Receptor Ligand for PET Scans in Neuropsychiatric Systemic Lupus Erythematosus No drug interventions Not Available Not Available completed NCT00198068
Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS) No drug interventions Not Available Not Available recruiting NCT05607368
Mast Cells Are Involved in the Mechanism of NPSLE Epilepsy No drug interventions Not Available Not Available recruiting NCT02219269
A Complex Contraception Registry No drug interventions Not Available Not Available completed NCT00137969
A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus treatment 2 / 3 completed NCT01305746
A Trial for Subjects With Systemic Lupus Erythematosus Who Have Completed Protocol AN-SLE3321 No drug interventions treatment 2 completed NCT01230112
The Role of ITGAM in Systemic Lupus Erythematosus No drug interventions Not Available Not Available completed NCT01716312
Omalizumab for Lupus treatment 1 completed NCT06535412
A Study of IMC-002 for the Treatment of Active Systemic Lupus Erythematosus No drug interventions treatment 1 / 2 not_yet_recruiting NCT03142412
Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization No drug interventions Not Available Not Available unknown_status NCT01741012
Study to Determine if Gardasil Vaccine is Safe and Effective in Lupus Patients prevention 1 completed NCT02270710
Molecular Mechanisms Characteristics in Systemic Lupus Erythematous Autoimmune Disease No drug interventions Not Available Not Available withdrawn NCT03063281
Anti-ficolin-2 Autoantibodies in Lupus Nephritis No drug interventions Not Available Not Available completed NCT00660881
Open-label Study of Epratuzumab in Serologically-positive Systemic Lupus Erythematosus Patients With Active Disease treatment 2 completed NCT01162681
PEARL-SC Trial: A Study of the Efficacy, Safety, and Tolerability of A 623 Administration in Subjects With Systemic Lupus Erythematosus No drug interventions treatment 2 completed NCT03296995
Accuracy, Feasibility and Acceptance of CGM Lupus No drug interventions screening Not Available unknown_status NCT00342095
Hormonal and Environmental Risk Factors for Developing Systemic Lupus Erythematosus: The Carolina Lupus (CLU) Study No drug interventions Not Available Not Available completed NCT02472795
Clinical Study to Investigate the Biological Activity, Safety, Tolerability, and Pharmacokinetics of ACT-334441 in Subjects With Systemic Lupus Erythematosus treatment 1 / 2 completed NCT02708095
A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus (SLE) treatment 2 completed NCT06153095
A Study of IMPT-514 in Active Refractory Systemic Lupus Erythematosus (SLE) No drug interventions treatment 1 / 2 recruiting NCT04356014
Telangiectatic Palmoplantar Keratoderma in Systemic and Subacute Lupus Erythematosus No drug interventions Not Available Not Available unknown_status NCT05639114
Phase 3 Study to Evaluate Two Regimens of Ianalumab on Top of Standard-of-care Therapy in Patients With Systemic Lupus Erythematosus (SIRIUS-SLE 1) treatment 3 recruiting NCT04942314
Practice of Treat-to-target on Pediatric Systemic Lupus Erythematosus: a Two-center Retrospective Study No drug interventions Not Available Not Available unknown_status NCT02842814
Prediction of Relapse Risk in Stable Systemic Lupus Erythematosus treatment Not Available completed NCT02922114
Comparison of the Clinical Examination and the Joint Ultrasonography in Lupus Patients No drug interventions diagnostic Not Available completed NCT00383214
Study of Epratuzumab in Systemic Lupus Erythematosus (SLE) treatment 3 terminated NCT05418855
Clinical Characteristics and Outcomes of SLE Patients Admitted to Critical Care Unit No drug interventions Not Available Not Available unknown_status NCT00055055
Study of Families With Twins or Siblings Discordant for Rheumatic Disorders No drug interventions Not Available Not Available completed NCT05869955
A Study of CC-97540, CD-19-Targeted Nex-T CAR T Cells, in Participants With Severe, Refractory Autoimmune Diseases treatment 1 recruiting NCT00006055
Autologous Peripheral Blood Stem Cell Transplantation in Patients With Life Threatening Autoimmune Diseases treatment Not Available unknown_status NCT03734055
Peer Approaches to Lupus Self-management No drug interventions health_services_research Not Available active_not_recruiting NCT01729455
Safety and Effectiveness of BENLYSTA (Belimumab) in Systemic Lupus Erythematosus (SLE) Registry Not Available Not Available active_not_recruiting NCT01520155
CArdiovascular Risk Assessment STudy in Lupus Erythemathodes (CASTLE) No drug interventions Not Available Not Available completed NCT06340750
BAFF CAR-T Cells (LMY-920) for Systemic Lupus Erythematosus No drug interventions treatment 1 not_yet_recruiting NCT02330250
Effectiveness of Pharmaceutical Care in the Adherence of Systemic Lupus Erythematosus Treatment No drug interventions supportive_care Not Available completed NCT03276923
Maternal Autoimmune Disease Research Alliance (MADRA) Registry No drug interventions Not Available Not Available recruiting NCT01322308
Effect of Pioglitazone on Endothelial Function in Premenopausal Women With Uncomplicated Systemic Lupus Erythematosus treatment 4 completed NCT00011908
Humanized LL2IGG to Treat Systemic Lupus Erythematosus treatment 1 completed NCT06297408
Relma-cel for Moderate to Severe Active Systemic Lupus Erythematosus treatment 1 not_yet_recruiting NCT01488708
On Open-Label Study in Participants With Systemic Lupus Erythematosus treatment 3 terminated NCT04580108
Highly Sensitive Serum Cardiac Troponin T and Cardiovascular Events in Patients With Systemic Lupus Erythematosus No drug interventions Not Available Not Available completed NCT03687138
Searching for Diagnostic/Prognostic Biomarkers in SLE With Renal Involvement by Proteomic Techniques No drug interventions Not Available Not Available completed NCT02084238
Low-dose IL-2( Interleukin-2) Treatment in SLE treatment Not Available completed NCT01205438
A Study of LY2127399 in Participants With Systemic Lupus Erythematosus treatment 3 completed NCT03735238
Implementing the Decision-Aid for Lupus (IDEAL Strategy) No drug interventions Not Available Not Available active_not_recruiting NCT01018238
An Investigation of NNC 0151-0000-0000 in Subjects With Systemic Lupus Erythematosus (SLE) No drug interventions treatment 1 withdrawn NCT05253638
Evaluation Of Serum MIF Level in SLE Patients No drug interventions diagnostic Not Available unknown_status NCT03933943
A Study of LY3361237 in Participants With Systemic Lupus Erythematosus basic_science 1 completed NCT06349343
CD19/BCMA HLA-independent TCR-T Cell Therapy for Refractory/Moderate-to-severe Systemic Lupus Erythematosus No drug interventions treatment 1 not_yet_recruiting NCT01176643
Development and Evaluation of Modified Yoga in Systemic Lupus Erythematosus (SLE) No drug interventions supportive_care Not Available completed NCT06255743
(Anti-Ribosomal P Protein,Anti-U1 RNP, Anti-Nucleosome and Anti-ds DNA Antibodies) and Relation to Depression and Anxiety in SLE No drug interventions diagnostic Not Available recruiting NCT03103243
Pilot Study to Investigate Contemplative Intervention in Lupus Patients No drug interventions treatment Not Available completed NCT02307643
Exploratory Study of MT-1303 in Systemic Lupus Erythematosus Patients No drug interventions treatment 1 completed NCT05843643
Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus treatment 3 recruiting NCT06151990
Assessment of Lipid Profile in Juvenile Systemic Lupus Erythematosus No drug interventions Not Available Not Available recruiting NCT01559090
Safety and Tolerability of Intravenous Dose of MEDI-546 in Japanese Subjects With Systemic Lupus Erythematosus. treatment 2 completed NCT00278590
Allogeneic Stem Cell Transplantation in Systemic Lupus Erythematosus No drug interventions treatment 1 withdrawn NCT04213690
A Pilot Study to Explore the Role of Gut Flora in Lupus No drug interventions Not Available Not Available unknown_status NCT05590390
Osteoporosis and Fragility Fractures Among SLE Patients. (FRAIL Trial) No drug interventions Not Available Not Available active_not_recruiting NCT02437890
A Phase II Study to Evaluate Safety and Efficacy of ALX-0061 in Subjects With Systemic Lupus Erythematosus treatment 2 completed NCT00368264
TNF Blockade With Remicade in Active Lupus Nephritis WHO Class V (TRIAL ) treatment 2 / 3 terminated NCT02665364
Phase IIb Study of IFN-K in Systemic Lupus Erythematosus No drug interventions treatment 2 terminated NCT03684564
RIvaroxaban for Stroke Patients With AntiPhospholipid Syndrome treatment 2 active_not_recruiting NCT04239521
The Epidemiology, Management, and the Associated Burden of Related Conditions in Alopecia Areata No drug interventions Not Available Not Available completed NCT00911521
Immunogenicity and Safety of a Quadrivalent Human Papillomavirus (HPV) Vaccine in Patients With SLE: a Controlled Study prevention 4 completed NCT00000421
Serologically Active, Clinically Stable Systemic Lupus Erythematosus treatment 2 completed NCT05880121
Neuron-specific Humoral and Cellular Immune Correlates of Structural and Functional Brain Connectomics in Neuropsychiatric Lupus No drug interventions Not Available Not Available recruiting NCT04358302
Individual Patient Exposure and Response in Pediatric Lupus No drug interventions supportive_care Not Available completed NCT05426902
Utilizing Qualitative and Quantitative Methods to Understand a New Model of Type 1 and 2 Systemic Lupus Erythematosus (SLE) No drug interventions health_services_research Not Available completed NCT04355702
Covid-19 in Lupus Patients No drug interventions Not Available Not Available completed NCT04077684
Efficacy and Safety of Low-dose IL-2 in Patients With SLE: a Multicenter, Randomised, Placebo-controlled Trial treatment 2 recruiting NCT04110184
Haematological Indices in Systemic Lupus Erythematosus No drug interventions Not Available Not Available unknown_status NCT04983784
The Effectiveness of Walking in Patients With Systemic Lupus Erythematosus No drug interventions health_services_research Not Available unknown_status NCT03254784
A Study to Evaluate BMS-986165 Tablet Formulation Relative to BMS-986165 Capsule Formulation and the Effect of a High-Fat/ High-Calorie Meal and Increased Gastric pH on the BMS-986165 Tablet Formulation treatment 1 completed NCT01549184
Retrospective Analysis of the Safety and Efficacy of Hydroxychloroquine in Immune Thrombocytopenia No drug interventions Not Available Not Available completed NCT04956484
Belimumab In Early Systemic Lupus Erythematosus treatment 4 completed NCT05430087
Vitamin D and Curcumin Piperine Attenuates Disease Activity and Cytokine Levels in Systemic Lupus Erythematosus Patients treatment 2 completed NCT00418587
Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE) treatment 1 completed NCT00120887
Lupus Atherosclerosis Prevention Study prevention 4 completed NCT00006133
Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus treatment Not Available completed NCT05430854
Study of Daxdilimab (HZN-7734) for the Treatment of Systemic Lupus Erythematosus in an Open-label Extension Study treatment 2 terminated NCT04810754
An Open Label Study to Evaluate Daratumumab in Participants With Moderate to Severe Systemic Lupus Erythematosus treatment 2 unknown_status NCT01697254
The CARRA Registry No drug interventions Not Available Not Available completed NCT02477254
Long-term Immunogenicity of a HPV Vaccine in SLE No drug interventions Not Available Not Available completed NCT02925351
Fluorine F 18 Clofarabine PET/CT in Imaging Patients With Autoimmune or Inflammatory Diseases No drug interventions diagnostic 0 completed NCT04857151
Stress, Inflammation and Immune Response Pilot Study- Aim 3 No drug interventions basic_science 0 completed NCT01852851
Employment and Arthritis: Making it Work No drug interventions supportive_care Not Available unknown_status NCT00203151
A Study to Evaluate the Tolerability, Safety and Effectiveness of Edratide in the Treatment of Lupus treatment 2 terminated NCT03427151
Study of Repeated Administration of a 200-mcg Dose of IPP-201101 Plus Standard of Care in Patients With Systemic Lupus Erythematosus treatment 3 completed NCT03334851
Safety and Tolerability Study Of PF-06835375 In Subjects With Seropositive Systemic Lupus Erythematosus Or Rheumatoid Arthritis No drug interventions basic_science 1 completed NCT00392951
Sirolimus for Autoimmune Disease of Blood Cells treatment 1 / 2 completed NCT06222853
Study of Therapeutic Efficacy of Anti-CD19 CAR-T Cells in Children With Refractory Systemic Lupus Erythematosus No drug interventions treatment 1 recruiting NCT03583853
Autophagy in Systemic Lupus Erythematosus No drug interventions Not Available Not Available unknown_status NCT05704153
Modelling and Control of Non-invasive Vagus Nerve Stimulation for Autoimmune Diseases (1A) No drug interventions screening Not Available recruiting NCT04736953
Sirolimus Treatment Of Patients With SLE treatment 2 not_yet_recruiting NCT04447053
Sequential Belimumab and T-cell Based Therapy in SLE basic_science 4 recruiting NCT01345253
GSK1550188 A 52 Week Study of Belimumab Versus Placebo in the Treatment of Subjects With Systemic Lupus Erythematosus (SLE) Located in Northeast Asia treatment 3 completed NCT05617677
A Study to Assess Effectiveness and Safety of Deucravacitinib Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) treatment 3 recruiting NCT05451277
At the Heart of the Matter - Speckle Tracking Echocardiography in Lupus Mothers and Their Offspring No drug interventions Not Available Not Available unknown_status NCT00849745
Nonmyeloablative Allo Stem Cell Transplant for Severe Autoimmune Diseases No drug interventions treatment 1 terminated NCT06361745
Early Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases No drug interventions treatment Not Available recruiting NCT04136145
Single Dose Study to Investigate the Pharmacokinetics (PK) and Safety of Belimumab 200 Milligrams (mg) Intravenous and 200 mg Subcutaneous Via Auto-injector in Chinese Healthy Subjects treatment 1 completed NCT05155345
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Subcutaneously Administered Mosunetuzumab to Participants With Systemic Lupus Erythematosus treatment 1 active_not_recruiting NCT03816345
Nivolumab in Treating Patients With Autoimmune Disorders and Advanced, Metastatic, or Unresectable Cancer treatment 1 recruiting NCT06570798
A Phase 2a Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases treatment 2 not_yet_recruiting NCT00508898
The Efficacy and Safety of Calcitriol for the Treatment of Lupus Nephritis and Persistent Proteinuria treatment 4 withdrawn NCT05001698
Anifrolumab PK Study for Systemic Lupus Erythematosus (SLE) treatment 1 completed NCT02847598
Study to Evaluate BIIB059 (Litifilimab) in Cutaneous Lupus Erythematosus (CLE) With or Without Systemic Lupus Erythematosus (SLE) treatment 2 completed NCT06417398
Preliminary Clinical Study of UTAA09 Injection in the Treatment of Relapsed/Refractory Autoimmune Diseases No drug interventions treatment 0 not_yet_recruiting NCT00610805
Cardiology Prevention in Systemic Lupus Erythematosus (SLE) No drug interventions prevention Not Available withdrawn NCT03746197
Interactive Digital Technology to Assess and Improve Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus No drug interventions supportive_care Not Available unknown_status NCT04305197
A Study of ICP-022 in Patients With Systemic Lupus Erythematosus (SLE) treatment 1 / 2 completed NCT06333483
A Study of CD19 Targeted CAR T Cell Therapy in Patients With Severe, Refractory Systemic Lupus Erythematosus (SLE) treatment 1 recruiting NCT06294483
Comparison Between Early-onset and Late-onset Patients With Systemic Lupus Erythematosus. No drug interventions Not Available Not Available enrolling_by_invitation NCT02349061
A Phase 2a, Efficacy and Safety Study of Ustekinumab in Systemic Lupus Erythematosus treatment 2 completed NCT03953261
Effect of Curcumin on Systemic Lupus Erythematosus treatment 2 terminated NCT02988661
Women Empowered to Live With Lupus Study No drug interventions treatment Not Available active_not_recruiting NCT03746028
The Lupus prEGnAnCY Cohort: An International Prospective Cohort of Lupus Pregnancies No drug interventions Not Available Not Available unknown_status NCT04180228
Human Papilloma Virus Vaccination and Chronic Inflammatory Rheumatic Diseases. No drug interventions Not Available Not Available completed NCT05516511
Serum Levels of Angiotensin Converting Enzyme in Systemic Lupus Erythematous Patients No drug interventions Not Available Not Available not_yet_recruiting NCT01781611
Dipyridamole Assessment for Flare Reduction in Systemic Lupus Erythematosus (SLE) treatment Not Available terminated NCT01093911
Safety Study of CDP7657 in Healthy Volunteers and Patients With Systemic Lupus Erythematosus (SLE) Not Available 1 completed NCT00082511
GL701 (Prestara™) in Women With Systemic Lupus Erythematosus Receiving Treatment With Glucocorticoids treatment 3 completed NCT00611611
BLYS and IFN in SLE Not Available Not Available completed NCT06106893
A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus Erythematosus No drug interventions treatment 1 / 2 recruiting NCT04186871
Study to Assess Safety and Effectiveness of Branebrutinib Treatment in Participants With Active Systemic Lupus Erythematosus or Primary Sjögren's Syndrome, or Branebrutinib Treatment Followed by Open-label Abatacept Treatment in Study Participants With Active Rheumatoid Arthritis treatment 2 completed NCT02037971
Aerobic Exercise on Improving Sleep in Systemic Lupus Erythematosus. No drug interventions health_services_research Not Available unknown_status NCT06056778
The Prevalence Evaluation of Systemic Lupus Erythematosus in Russian Patients With Reproductive Issues (PRISMA) No drug interventions Not Available Not Available completed NCT00235378
Genetic Study of Lupus Patients and Their Families No drug interventions Not Available Not Available completed NCT00005778
High-Dose Intravenous (IV) Cyclophosphamide Versus Monthly IV Cyclophosphamide No drug interventions treatment 3 completed NCT00747578
Health-Related Quality of Life and Disease-Related Costs: Comparison Between Ankylosing Spondylitis, Rheumatoid Arthritis and Systemic Lupus Erythematosus in Taiwan No drug interventions Not Available Not Available unknown_status NCT04882878
A Study of Nipocalimab in Adult Participants With Active Systemic Lupus Erythematosus treatment 2 active_not_recruiting NCT01956188
Omega 3 in LES and APS No drug interventions supportive_care Not Available unknown_status NCT00188188
Study of Endothelial Dysfunction in Systemic Lupus and Its Role in Heart Disease No drug interventions treatment 4 unknown_status NCT05620407
A Study to Evaluate Effectiveness and Safety of Deucravacitinib (BMS-986165) Compared With Placebo in Participants With Active Systemic Lupus Erythematosus treatment 3 recruiting NCT04397107
The Therapeutic Value and Mechanism of Recombinant Human Interleukin-2 on Children With Rheumatic Diseases treatment Not Available completed NCT04902807
Conception of a Diagnosis, Prognosis and Therapeutic Decision Tool for Patients With Autoimmunity and Inflammation No drug interventions Not Available Not Available not_yet_recruiting NCT06188507
A First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK4347859 in Healthy Participants No drug interventions treatment 1 not_yet_recruiting NCT05659407
BAFF-var as a Biomarker of Response to B-depletive Treatment in Systemic Lupus Erythematosus and Rheumatoid Arthritis Not Available Not Available recruiting NCT00657007
Phase 1 Study of Belimumab in Subjects With Systemic Lupus Erythematosus (SLE) treatment 1 completed NCT00125307
Tacrolimus for the Treatment of Systemic Lupus Erythematosus With Membranous Nephritis treatment 4 completed NCT04411407
PROM Collected Via a WebApp Versus a Touch Screen Solution Among Patients With SLE No drug interventions other Not Available completed NCT02151409
Dose-escalation Trial of Anti-C5aR Antibody in Healthy Subjects No drug interventions treatment 1 completed NCT02321709
Multiple Ascending Dose Study To Assess The Safety Profile Of SAR113244 Versus Placebo In Lupus Male And Female Patients No drug interventions basic_science 1 completed NCT01840709
Effectiveness Study of Psychotherapy in Systemic Lupus Erythematosus No drug interventions health_services_research Not Available unknown_status NCT01687309
A Study to Investigate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Single and Repeat Doses of GSK2586184 and the Effect of Food and Gender No drug interventions treatment 1 completed NCT00786409
Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women prevention Not Available completed NCT03575156
Microparticles's Role in the Pathophysiology of Systemic Lupus Erythematosus and Systemic Sclerosis No drug interventions other Not Available completed NCT00004756
Study of Individualized Instruction Versus Pamphlet in Systemic Lupus Erythematosus No drug interventions educational_counseling_training Not Available completed NCT01777256
An Adaptive Phase II Study to Evaluate the Efficacy, Pharmacodynamics, Safety and Tolerability of GSK2586184 No drug interventions treatment 2 terminated NCT02119156
Belimumab Treatment Holiday and Treatment Re-start Study in Lupus Patients treatment 3 completed NCT01923415
A Non-drug Study Profiling Cutaneous Lupus No drug interventions Not Available Not Available completed NCT02955615
ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE) treatment 2 completed NCT02403115
Prediction of Outcome of Lupus Nephritis No drug interventions Not Available Not Available unknown_status NCT02932137
Anti-infection of Low-does IL-2 in SLE prevention Not Available completed NCT00382837
Study of Epratuzumab in Systemic Lupus Erythematosus treatment 3 withdrawn NCT05001737
Evaluate Efficacy, Safety and Tolerability, PK and PD of Emapalumab in Children and Adults With MAS in Still's or SLE treatment 3 active_not_recruiting NCT00280137
Health-related Quality of Life Measure in Pediatric Lupus No drug interventions Not Available Not Available completed NCT00594932
Biomarker-Linked Outcomes of Cellcept in Lupus Arthritis treatment 1 / 2 completed NCT00962832
A Study to Evaluate the Efficacy and Safety of Rontalizumab in Patients With Moderately to Severely Active Systemic Lupus Erythematosus treatment 2 completed NCT01327352
Evaluation of the Influence of Food Regimen on Oshadi D Absorption No drug interventions Not Available Not Available completed NCT00076752
Lymphocyte Depletion and Stem Cell Transplantation to Treat Severe Systemic Lupus Erythematosus treatment 2 completed NCT03915652
Addressing Disparities in Lupus Care Through an Integrated Care Management Program No drug interventions health_services_research Not Available active_not_recruiting NCT05358652
Precision Medicine in LN: A Multicenter Proof-of-concept Study for Histopathological Biomarkers Analysis in Renal Biopsy No drug interventions Not Available Not Available unknown_status NCT02908100
A Study of the Safety and Efficacy of GDC-0853 in Participants With Moderate to Severe Active Systemic Lupus Erythematosus treatment 2 completed NCT02194400
Dose Escalation Study of RSLV-132 in Subjects With Systemic Lupus Erythematosus No drug interventions treatment 1 completed NCT06227559
The Role of Some Hematological Parameters in Juvenile Systemic Lupue Erythematosus No drug interventions Not Available Not Available not_yet_recruiting NCT02391259
A Study to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of AMG 557 in Subjects With Systemic Lupus Erythematosus No drug interventions treatment 1 completed NCT03206359
GADD34 and Type I IFN Response Genes in SLE No drug interventions Not Available Not Available completed NCT04648059
Epigenetics in Lupus Nephritis No drug interventions Not Available Not Available unknown_status NCT01135459
A Study to Evaluate the Efficacy and Safety of CEP-33457 in Participants With Systemic Lupus Erythematosus (SLE) No drug interventions treatment 2 completed NCT06365359
Systemic Lupus Erythematosus and Chlordecone Impregnation in Martinique No drug interventions Not Available Not Available not_yet_recruiting NCT06458075
Intervention to Improve Communication and Medication Adherence in Lupus No drug interventions health_services_research Not Available recruiting NCT05243875
Lupus Education Alliance Program No drug interventions health_services_research Not Available recruiting NCT01837875
Intervention to Improve Quality of Life in African American Lupus Patients No drug interventions health_services_research Not Available completed NCT02422875
Comparative Autoantibody and Immunologic Cell Marker Study No drug interventions Not Available Not Available enrolling_by_invitation NCT04749875
Study of Leukocyte Populations in Patients With Chronic Inflammatory No drug interventions Not Available Not Available not_yet_recruiting NCT02732470
Effect of Qi Gong Training on Quality of Life in Patients With Systemic Lupus Erythematous (LuQi) No drug interventions prevention Not Available completed NCT02533570
Dose Ranging Study of Brentuximab Vedotin in Adults With Lupus treatment 2 terminated NCT05636670
Assessment of Cognitive Function and Gut Microbiota Analysis in Real World Patients With Lupus Cerebrovascular Disease No drug interventions Not Available Not Available recruiting NCT03107442
Exercise and Arterial Stiffness in Systemic Lupus Erythematosus No drug interventions treatment Not Available completed NCT05748899
Effect of Applying Ujjayi Pranayama on Cortisol in Lupus Patients No drug interventions treatment Not Available recruiting NCT02338999
Role of PPAR-y Agonists in Immunomodulation and Vascular Prevention in SLE (PPAR-SLE) prevention 1 / 2 completed NCT00752999
Efficacy and Safety Study of R935788 Tablets to Treat Systemic Lupus Erythematosus treatment 2 withdrawn NCT05791799
Etonogestrel Implants Protect Ovarian Reserve Function in Systemic Lupus Erythematosus prevention 2 / 3 not_yet_recruiting NCT06166199
Effects of High-intensity Interval Training in Patients With Systemic Lupus Erythematosus No drug interventions treatment Not Available recruiting NCT04570306
Transcriptional and Immune Parameters of Response to Belimumab Not Available Not Available completed NCT02443506
A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of Single Dose of AMG 623 in Subjects With Systemic Lupus Erythematosus No drug interventions treatment 1 completed NCT04671706
Belimumab in Patients With Systemic Lupus Erythematosus No drug interventions Not Available Not Available not_yet_recruiting NCT01475149
Effect of HCQ on AnxA5 Resistance Assay in Antiphospholipid (aPL) Positive Patients With and Without Systemic Lupus Erythematosus (SLE) No drug interventions Not Available Not Available completed NCT05029336
Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases No drug interventions treatment 2 recruiting NCT01381536
Phase I Study of GSK1550188 in Japanese Subjects With Systemic Lupus Erythematosus (SLE) No drug interventions treatment 1 completed NCT02411136
A Study to Examine the Safety, Pharmacokinetics and Pharmacodynamics of AMG 623 in Subjects With Systemic Lupus Erythematosus No drug interventions treatment 1 completed NCT04582136
Efficacy and Safety of Sirolimus in Active Systemic Lupus Erythematosus treatment 2 recruiting NCT06378736
Electroencephalogram Recording in Patients With Systemic Lupus Erythematosus No drug interventions Not Available Not Available recruiting NCT02711813
TAB08 in Patients With Systemic Lupus Erythematosus (SLE), Not Adequately Controlled With Current Treatment treatment 2 terminated NCT00483613
Effects of Treatment of Chronic Stress in Patients With Lupus No drug interventions supportive_care Not Available completed NCT00383513
Study of Epratuzumab in Systemic Lupus Erythematosus treatment 2 completed NCT06479213
REACH (Restore Energy, Activity Can Help) Lupus Study No drug interventions health_services_research Not Available recruiting NCT02021513
Pilot Study - Effect of Omega-3 on Systemic Lupus Erythematosus No drug interventions treatment 2 completed NCT06073613
Periodontal Status in Patients With Chronic Skin Diseases No drug interventions Not Available Not Available completed NCT04486118
Centrally Acting ACE Inhibition in SLE treatment 2 recruiting NCT05179018
Clinical and Diagnostic Value of Ribosomal p2 Autoantibodies in Systemic Lupus Erythematosus No drug interventions Not Available Not Available unknown_status NCT00000419
Safety of Estrogens in Lupus: Hormone Replacement Therapy treatment 3 terminated NCT04515719
Efficacy and Safety of Belimumab in SLE Patients prevention 4 unknown_status NCT05879419
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases prevention 4 recruiting NCT04835441
ALPN-101 (Acazicolcept) in Systemic Lupus Erythematosus treatment 2 active_not_recruiting NCT04895241
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus treatment 3 recruiting NCT00017641
Phase I Study of Immune Ablation and CD34+ Peripheral Blood Stem Cell Support in Patients With Systemic Lupus Erythematosus treatment 1 unknown_status NCT00325741
Allogeneic Blood Stem Cell Transplantation for Patients With Life-Threatening Systemic Lupus Erythematosus No drug interventions treatment 1 terminated NCT05798117
An Open-label, Study to Assess Safety, Efficacy and Cellular Kinetics of YTB323 in Severe, Refractory Systemic Lupus Erythematosus No drug interventions treatment 1 / 2 recruiting NCT05631717
The Study of Comparing the Efficacy and Safety of Human Umbilical Cord MSCs and Low-dose IL-2 in the Treatment of LN treatment 3 recruiting NCT05045417
IL17 in Systemic Lupus Erythematosus Patients: Association With Disease Activity and Organ Damage No drug interventions Not Available Not Available unknown_status NCT03845517
A DOSE-RANGING STUDY TO EVALUATE EFFICACY AND SAFETY OF PF-06700841 IN SYSTEMIC LUPUS ERYTHEMATOSUS (SLE) treatment 2 completed NCT03189017
A Phase I Study of ICP-022 in Healthy Subjects No drug interventions treatment 1 completed NCT05157334
The Effect of Deep Breathing and Transcutaneus Electrical Nerve Stimulation on Heart Rate Variability No drug interventions basic_science Not Available unknown_status NCT00271934
Immune Ablation and Hematopoietic Stem Cell Support in Patients With Systemic Lupus Erythematosus: A Phase II Study No drug interventions treatment 2 completed NCT00006134
Study of the Predictors of the Course and Early Outcome of Patients With Systemic Lupus Erythematosus: Nature Versus Nurture No drug interventions Not Available Not Available completed NCT04925934
Study of VIB7734 for the Treatment of Moderate to Severely Active SLE treatment 2 completed NCT03817424
A Study to Evaluate VIB7734 in Participants With Systemic Lupus Erythematosus (SLE), Cutaneous Lupus Erythematosus (CLE), Sjogren's Syndrome, Systemic Sclerosis, Polymyositis, and Dermatomyositis treatment 1 completed NCT00391924
Dehydroepiandrosterone Administration in Women With Systemic Lupus Erythematosus or Primary Sjögren's Syndrome treatment 2 completed NCT00189124
Dehydroepiandrosterone (DHEA) in Systemic Lupus Erythematosus (SLE) for Coronary Artery Disease (CAD) Prevention treatment 2 / 3 completed NCT03952624
Patient-Centered Assessment of Symptoms and Outcomes No drug interventions Not Available Not Available recruiting NCT04082416
Study of Recombinant Human B Lymphocyte(RC18) Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE) No drug interventions treatment 3 completed NCT06549296
Clinical Study on Targeted CD19CAR-T Therapy for Autoimmune Diseases No drug interventions treatment 0 not_yet_recruiting NCT04895696
A Study Evaluating the Efficacy and Safety of Afimetoran Compared With Placebo in Participants With Active Systemic Lupus Erythematosus (SLE) treatment 2 recruiting NCT01405196
Subcutaneous Treatment In Randomized Subjects To Evaluate Safety And Efficacy In Generalized Lupus Erythematosus treatment 2 completed NCT02450396
Pregnancy and Medically Assisted Conception in Rare Diseases No drug interventions Not Available Not Available recruiting NCT04751396
Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors No drug interventions Not Available Not Available recruiting NCT04032496
Contemplation-Based Intervention and Health Outcomes RCT in Lupus Patients No drug interventions basic_science Not Available unknown_status NCT00010335
Pilot Study of Total Body Irradiation in Combination With Cyclophosphamide, Anti-thymocyte Globulin, and Autologous CD34-Selected Peripheral Blood Stem Cell Transplantation in Children With Refractory Autoimmune Disorders No drug interventions treatment 1 completed NCT00230035
Lupus Immunosuppressive/Immunomodulatory Therapy or Stem Cell Transplant (LIST) treatment 2 withdrawn NCT01953835
A Two-part Study to Investigate the Interaction and Pharmacokinetics of GSK2586184 treatment 1 completed NCT03312335
Low-dose Interleukin-2 for Treatment of Systemic Lupus Erythematosus basic_science 2 completed NCT00611663
Safety Study of Two Vaccine Strategies in Patients With Systemic Lupus Erythematosus No drug interventions treatment 2 / 3 completed NCT00004663
Epidemiologic Study of Reproductive Outcome in Women With Systemic Lupus Erythematosus No drug interventions Not Available Not Available completed NCT00519363
Statins and Lupus: Effects of Statins on Clinical Lupus Parameters, Serological Markers and Toll-like Receptors treatment 1 / 2 completed NCT05116163
Breaking Implicit Bias Habits: An Individuation Pilot Study In Rheumatology No drug interventions health_services_research Not Available active_not_recruiting NCT05278663
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of E6742 in Systemic Lupus Erythematosus Participants No drug interventions treatment 1 / 2 completed NCT06559163
A Study of Obexelimab in Patients With Systemic Lupus Erythematosus treatment 2 not_yet_recruiting NCT02633163
Phase 2 Trial of Mesenchymal Stem Cells in Systemic Lupus Erythematosus (MiSLE) treatment 2 recruiting NCT04402086
Rheumatology Patient Registry and Biorepository No drug interventions Not Available Not Available recruiting NCT05123586
A IMMA Master Protocol: A Study of LY3361237 in Participants With at Least Moderately Active Systemic Lupus Erythematosus treatment 2 terminated NCT03125486
Compassionate Use for Subcutaneous (SC) Belimumab Not Available Not Available no_longer_available NCT05162586
The WILLOW Study With M5049 in SLE and CLE (SCLE and/or DLE) (WILLOW) treatment 2 active_not_recruiting NCT06411639
Pharmacokinetics Study of Ianalumab in Chinese Participants With Autoimmune Diseases treatment 1 not_yet_recruiting NCT03543839
Trial of Belimumab in Early Lupus treatment 4 recruiting NCT03446339
Pulmonary Hypertension Screening for Rheumatology Patients (SOPHIE) No drug interventions Not Available Not Available unknown_status NCT06228222
Predictors of Remission and Renal Outcomes in Lupus Nephritis in Assuit University Hospitals. No drug interventions Not Available Not Available not_yet_recruiting NCT00470522
Study of Methotrexate in Lupus Erythematosus treatment 3 completed NCT03517722
A Study of Ustekinumab in Participants With Active Systemic Lupus Erythematosus treatment 3 terminated NCT05379725
Mediterranean vs. High-Fermented-Food Diet Adherence on Inflammation in Lupus No drug interventions other Not Available active_not_recruiting NCT02319525
Individualized Patient Decision Making for Treatment Choices Among Minorities With Lupus No drug interventions supportive_care Not Available completed NCT05763225
Validation of Patient E-tool to Measure Systemic Lupus Activity No drug interventions Not Available Not Available completed NCT03843125
A Study of Baricitinib in Participants With Systemic Lupus Erythematosus (SLE) treatment 3 terminated NCT01689025
An Investigation of Safety and Tolerability of NNC0114-0006 in Subjects With Systemic Lupus Erythematosus (SLE) treatment 1 terminated NCT00417430
Efficacy of Faslodex in Treatment of SLE Clinical, Serologic, and Molecular Studies treatment 2 completed NCT00818948
Safety Study of AMG 811 in Subjects With Systemic Lupus Erythematosus With and Without Glomerulonephritis No drug interventions treatment 1 completed NCT03200548
Acupressure for Fatigue in Systemic Lupus Erythematosus No drug interventions treatment Not Available terminated NCT02270957
Clarification of Abatacept Effects in SLE With Integrated Biologic and Clinical Approaches treatment 2 completed NCT04750057
Anifrolumab Early Access Program Not Available Not Available no_longer_available NCT02320357
Pilot Study Related to the Effect of Clopidogrel on Plasmatic Soluble CD40 Ligand During Systemic Lupus Erythematous treatment 1 / 2 completed NCT05328557
A Phase Ia Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of Subcutaneously Administered CUG252 in Normal Healthy Volunteers No drug interventions treatment 1 active_not_recruiting NCT00188357
HIPP Learning to Live Better With Lupus: The Health Improvement and Prevention Program in Systemic Lupus Erythematosus No drug interventions prevention Not Available unknown_status NCT01359826
The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients treatment 4 withdrawn NCT05687526
A Study of Telitacicept in Subjects With Childhood-onset Systemic Lupus Erythematosus treatment 1 recruiting NCT03949426
Safety, Tolerability and Pharmacokinetics of KPG-818 in Healthy Subjects No drug interventions treatment 1 completed NCT01269866
Study of Duloxetine in the Reduction of Pain in Patient With Systemic Lupus Erythematosus treatment Not Available completed NCT04440566
O-GlcNAcylation Role in the Pathophysiology of Systemic Lupus Erythematosus No drug interventions other Not Available completed NCT00004665
Phase II Study of Long-Term Dehydroepiandrosterone for Systemic Lupus Erythematosus treatment 2 completed NCT02917265
Transcutaneous Vagus Nerve Stimulation for the Treatment of Lupus No drug interventions treatment 2 terminated NCT03348774
Scrutinizing the Heterogeneity of SLE: Defining Phenotypes No drug interventions Not Available Not Available unknown_status NCT02554474
OPAM-IA: Using Digital Activity Trackers to Improve Physical Activity in Inflammatory Arthritis No drug interventions supportive_care Not Available completed NCT01709474
Vitamin D3 Treatment in Pediatric Systemic Lupus Erythematosus treatment 2 terminated NCT01474720
Zostavax in Systemic Lupus Erythematosus prevention 1 completed NCT02074020
CHABLIS-SC2: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis treatment 3 withdrawn NCT05967520
JMKX000189 for Moderate to Severe Active Systemic Lupus Erythematosus No drug interventions treatment 2 recruiting NCT00563082
Analyzing the Association of Gene Variants With Increased Risk of Coronary Heart Disease in Women With Systemic Lupus Erythematosus No drug interventions Not Available Not Available completed NCT06238531
A Clinical Trial to Evaluate Safety of Gusacitinib in Patients With Systemic Lupus Erythematosus (SLE) or Lupus treatment 1 not_yet_recruiting NCT04786431
Shotgun Mass Spectrometry-based Lipid Profiling in Chronic Inflammatory Diseases No drug interventions Not Available Not Available completed NCT05329831
Effects of Telehealth Initiative on Lupus Patients No drug interventions supportive_care Not Available completed NCT03896373
Role of the Neonatal Fc Receptor for IgG in the Pathophysiology of Lupus No drug interventions Not Available Not Available completed NCT02799173
Determination of the RANKL/Osteoprotegerin Ratio in Patients With Systemic Lupus Erythematosus. Role in Osteoporosis and Cardiovascular Calcification No drug interventions basic_science Not Available completed NCT06448273
A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacokinetic of TQB3702 Tablets in Healthy Adult Subjects No drug interventions treatment 1 recruiting NCT05306873
Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus treatment 2 recruiting NCT00074373
The Research Registry for Neonatal Lupus No drug interventions Not Available Not Available completed NCT05424627
Myeloid Derived Suppressor Cells in Systemic Lupus Erythematosus No drug interventions Not Available Not Available not_yet_recruiting NCT00001676
Cyclophosphamide and Fludarabine to Treat Lupus Nephritis treatment 1 completed NCT06316076
Safety and Efficacy Study of CD19-CAR-DNT Cells in Autoimmune Diseases treatment 1 recruiting NCT00527176
Pulse Corticosteroid Therapy and Effect on Brain Water Diffusivity No drug interventions Not Available Not Available unknown_status NCT03042260
Prophylactic Trimethoprim/Sulfamethoxazole to Prevent Severe Infections in Patients With Lupus Erythematous prevention 4 unknown_status NCT02741960
The Effect of Metformin on Reducing Lupus Flares treatment 4 completed NCT04266860
Establishing Clinical Utility of a New Diagnostic Test for Rheumatology Patients No drug interventions diagnostic Not Available completed NCT03186794
Aerobic Exercise in Women With Systemic Lupus Erythematosus No drug interventions supportive_care Not Available terminated NCT01838694
Double-Blinded, Randomized, Placebo-Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Biochemical Activity of Intravenous Cpn10 Administration in Subjects With Mild to Moderate SLE. No drug interventions treatment 1 / 2 completed NCT00390091
Study of LJP 394 (Abetimus Sodium) in Lupus Patients diagnostic 2 withdrawn NCT06373991
A Study to Evaluate the Safety and Efficacy of ATHENA CAR-T in Subjects With Systemic Lupus Erythematosus treatment 1 not_yet_recruiting NCT04877691
Subcutaneous Anifrolumab in Adult Patients With Systemic Lupus Erythematosus treatment 3 recruiting NCT05859191
Study of Neonatal IgG Fc Receptor Expression in Natural Killer T Cells Expressing an Invariant T Receptor : Implication in the Pathophysiology of Systemic Lupus No drug interventions Not Available Not Available recruiting NCT01196091
A Study of LY2127399 in Participants With Systemic Lupus Erythematosus treatment 3 completed NCT06316791
Exploratory Clinical Study of CNCT19 Anti CD19 Cell Therapy in the Treatment of Refractory Autoimmune Diseases treatment 0 recruiting NCT00036491
Anti-CD20 in Systemic Lupus Erythematosus treatment 1 / 2 completed NCT06581562
Open-label Single-Center Study to Evaluate the Safety and Efficacy of Combining Rituximab and AB-101 in B-cell Associated Autoimmune Diseases. treatment 1 recruiting NCT02741362
Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's Syndrome No drug interventions treatment 1 terminated NCT01351662
Balancing Lupus Experiences With Stress Strategies No drug interventions health_services_research 1 / 2 completed NCT06567080
JWCAR201 for the Treatment of Hematology Malignancy and Autoimmune Diseases No drug interventions treatment 1 not_yet_recruiting NCT01460680
Membrane Polyunsaturated Fatty Acid Content in Fibromyalgia and Systemic Lupus Erythematosus (SLE) No drug interventions Not Available Not Available unknown_status NCT02453880
Web-based CBT for Symptoms of Mild-to-Moderate Anxiety and Depression in Youth With Chronic Illness No drug interventions prevention Not Available completed NCT01582880
Use of Cross-linked Donor Corneas as Carriers for the Boston Keratoprosthesis treatment 1 / 2 completed NCT00094380
Treating Systemic Lupus Erythematosus (SLE) Patients With CTLA4-IgG4m (RG2077) treatment 1 / 2 completed NCT05689580
The Influence of Ketogenic Diet on Lupus Nephritis Patients' Immunity No drug interventions treatment Not Available unknown_status NCT04320680
Systemic Lupus Erythematosus Within the Framework of the Multidisciplinary Consultation No drug interventions diagnostic Not Available recruiting NCT00976729
NOX-E36 First-in-Human (FIH) Study No drug interventions treatment 1 completed NCT03480529
Monitoring the IMmUological TOXicity of Drugs No drug interventions Not Available Not Available completed NCT01712529
Physical Exercise, Endothelial Function and Progenitor Endothelial Cells in Systemic Lupus Erythematosus Patients No drug interventions treatment Not Available unknown_status NCT02306629
Study to Compare Properties of Epratuzumab When Given as an Injection Under the Skin or Directly Into the Blood treatment 1 completed NCT00657189
A Study to Evaluate Safety and Tolerability of Subcutaneous Doses of MEDI-545 in Subjects With Lupus treatment 2 completed NCT05863689
Microvascular Ocular Changes of Systemic Lupus Erythematous No drug interventions Not Available Not Available recruiting NCT05090189
Exercise and Nutrition Recommendations for Patients Using Glucocorticoids (ENRG) No drug interventions treatment Not Available unknown_status NCT02822989
Using the Cholinergic Anti-Inflammatory Pathway to Treat Systemic Lupus Musculoskeletal Pain No drug interventions treatment Not Available unknown_status NCT02609789
A Single Ascending Dose Study in Healthy Participants and Multiple Dose Study of JNJ-55920839 in Participants With Mild to Moderate Systemic Lupus Erythematosus No drug interventions treatment 1 completed NCT06551389
Follow-up of the Systemic Lupus Erythematosus Cohort as Part of the Multidisciplinary Consultation at Brest CHRU No drug interventions Not Available Not Available recruiting NCT02162992
Systemic Lupus Erythematous and Heart Conduction Disorders No drug interventions Not Available Not Available completed NCT01687192
Multicenter Trial Evaluating the Immunogenicity of HPV Vaccination in Girls on Immunosuppressive Therapy. other 2 completed NCT01931644
At-Home Research Study for Patients With Autoimmune, Inflammatory, Genetic, Hematological, Infectious, Neurological, CNS, Oncological, Respiratory, Metabolic Conditions No drug interventions Not Available Not Available completed NCT02660944
A Phase 2a of RSLV-132 in Subjects With Systemic Lupus Erythematosus (SLE) No drug interventions treatment 2 completed NCT02034344
A Study of Skin and Systemic Biomarkers In Patients With Active Cutaneous Lupus Erythematosus And In Healthy Volunteers No drug interventions Not Available Not Available completed NCT04400240
Care Coordination Approaches to Learning Lupus Self-management No drug interventions prevention Not Available completed NCT02185040
A Pilot Study of CC-220 to Treat Systemic Lupus Erythematosus. treatment 2 completed NCT01702740
A Study of the Safety and Pharmacokinetics of CNTO 136 in Patients With Cutaneous Lupus Erythematosus and Systemic Lupus Erythematosus No drug interventions treatment 1 completed NCT03504540
Comparison of Complement Factors and Genetic Polymorphisms of AMD Between Patients With Systemic Lupus Erythematosus (SLE) With and Without Retinal "Pseudo-drusen-like" Deposits: Case-control Study (PL-AMD) No drug interventions Not Available Not Available completed NCT05039840
Efficacy and Safety of Frexalimab (SAR441344) in the Treatment of Systemic Lupus Erythematosus treatment 2 recruiting NCT01845740
Phase Ib Study of SC Milatuzumab in SLE treatment 1 completed NCT03920267
Long-Term Safety and Efficacy Study of Deucravacitinib in Participants With Systemic Lupus Erythematosus treatment 2 active_not_recruiting NCT00724867
A Continuation Trial for Subjects With Lupus Who Completed Protocol HGS1006-C1056 in the United States treatment 3 completed NCT02514967
CHABLIS7.5: A Study of the Efficacy and Safety of Subcutaneous Blisibimod in Subjects With Systemic Lupus Erythematosus With or Without Nephritis treatment 3 terminated NCT04700267
A Study Evaluating the Effects of GLPG3970 Given as Oral Treatment for 12 Weeks in Adults With Systemic Lupus Erythematosus No drug interventions treatment 1 terminated NCT05961267
Study of Gynecological Follow-up of Patients With Autoimmune Disease or Inflammatory Rheumatism No drug interventions Not Available Not Available recruiting NCT04961567
A Study to Learn About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Systemic Lupus Erythematosus treatment 3 recruiting NCT04431167
Healthy Lifestyle Intervention in Patients With Systemic Lupus Erythematosus: The Living Well With Lupus Study No drug interventions treatment Not Available unknown_status NCT01471301
Ultrasound Evaluation of Hands in Patients With Systemic Lupus Erythematosus No drug interventions Not Available Not Available unknown_status NCT01076101
Autoimmunity in Sisters of Lupus Patients No drug interventions Not Available Not Available completed NCT06421701
Anti-CD19 CAR-NK Cells in Refractory/Relapsed Systemic Lupus Erythematosus treatment 1 recruiting NCT05141201
SAPHNELO Systemic Lupus Erythematosus Japan Post-Marketing Surveillance (PMS) No drug interventions Not Available Not Available active_not_recruiting NCT05539001
Screening Biomarkers for Severe Lupus Based on Multi-omics Studies No drug interventions Not Available Not Available recruiting NCT03219801
Umbilical Cord Derived Mesenchymal Stem Cells Therapy in Systemic Lupus Erythematosus No drug interventions treatment 0 unknown_status NCT06458972
Safety, Efficacy, and Compliance of Telitacicept in the Treatment of Systemic Lupus Erythematosus (SLE) No drug interventions Not Available Not Available recruiting NCT01157468
Catalytic Antibodies and Lupus in Martinique No drug interventions Not Available Not Available completed NCT01972568
Efficacy and Safety of Atacicept in Systemic Lupus Erythematosus treatment 2 completed NCT06360068
A Prospective, Single Arm, Open Label, Proof of Concept Clinical Study of Sulfasalazine in the Treatment of Active Systemic Lupus Erythematosus treatment 2 not_yet_recruiting NCT01330368
Spine Quantitative Computed Tomography (QCT) for the Assessment of Osteoporosis on Children No drug interventions Not Available Not Available completed NCT00756769
Systemic Lupus Erythematosus in Gullah Health No drug interventions Not Available Not Available recruiting NCT01911169
Vitamin D to Improve Endothelial Function in SLE prevention 2 completed NCT02756546
Circulating MicroRNAs in Understanding Pathogenesis of Systemic Lupus Erythematosis diagnostic 1 / 2 completed NCT04141046
LUPUS Brain: tACS to Target the Neurophysiology of Depression, Cognitive Deficits, and Pain in Patients With SLE No drug interventions basic_science Not Available terminated NCT03179046
Cardiac and Laboratory Findings in Patients With Systemic Lupus Erythematosus No drug interventions Not Available Not Available completed NCT06379646
An Clinical Study of YTS109 Cell Injection in Subjects With Recurrent/Refractory Autoimmune Disease No drug interventions treatment Not Available recruiting NCT03473912
Meir Medical Center Rheumatologic Biobank No drug interventions Not Available Not Available recruiting NCT05637112
A Treatment Effectiveness Study Among SLE Patients Receiving Anifrolumab in Routine Clinical Practice No drug interventions Not Available Not Available recruiting NCT05362812
Prediction of Lupus Renal Flares Study No drug interventions Not Available Not Available unknown_status NCT00001212
Drug Therapy in Lupus Nephropathy treatment 2 completed NCT03616912
A Study of Baricitinib (LY3009104) in Participants With Systemic Lupus Erythematosus treatment 3 terminated NCT02801812
Observational Multicenter Case-control Study to Assess Nailfold Capillary Abnormalities in Systemic Lupus Erythematosus No drug interventions Not Available Not Available unknown_status NCT05835310
An Efficacy and Safety Study of Intravenous Anifrolumab to Treat Systemic Lupus Erythematosus in Pediatric Participants treatment 3 recruiting NCT06350110
Fourth-gen CAR T Cells Targeting BCMA/CD19 for Refractory Systemic Lupus Erythematosus (SLE) No drug interventions treatment 1 / 2 not_yet_recruiting NCT01532310
Belimumab (BENLYSTA®) Pregnancy Registry Not Available Not Available completed NCT02331810
Pharmacodynamics Assessment Study After Single Subcutaneous Dose Of SAR113244 Versus Placebo In Lupus Male And Female Patients No drug interventions basic_science 1 withdrawn NCT02885610
Study of RC18 Administered Subcutaneously to Subjects With Systemic Lupus Erythematosus(SLE) No drug interventions treatment 2 completed NCT01060410
Exploration of Genotype Based Personalized Prescription of Cyclophosphamide in Systemic Lupus Erythematosus Treatment Not Available Not Available completed NCT00381810
A Study to Evaluate the Safety of Rituximab Retreatment in Subjects With Systemic Lupus Erythematosus treatment 3 terminated NCT04293510
Evaluation of Janus Kinase_3 in Juvenile Onset Systemic Lupus Erythematosus No drug interventions Not Available Not Available unknown_status NCT05057481
Reappraisal of the Therapies of Refractory Autoimmune Hemolytic Anemia in Systemic Lupus Erythematosus treatment 3 unknown_status NCT05916781
Effectiveness of Mycophenolate Mofetil Combined With Tacrolimus for Steroid Tapering in Systemic Lupus Erythematosus treatment 4 recruiting NCT05287581
Motivating Individuals With Lupus to Exercise No drug interventions supportive_care Not Available completed NCT02769195
Utility of a Measure of Lupus Low Disease Activity State (LLDAS) in SLE No drug interventions Not Available Not Available completed NCT00004795
Phase II/III Randomized, Double-Blind, Placebo-Controlled Study of Dehydroepiandrosterone in Women With Mild to Moderate Systemic Lupus Erythematosus treatment 2 / 3 completed NCT02524795
Omega 3 Fatty Acids and Systemic Lupus Erythematosus No drug interventions treatment Not Available completed NCT00124514
Triptorelin for Ovary Protection in Childhood Onset Lupus diagnostic 2 completed NCT02950714
Dissemination of the Lupus Interactive Navigator No drug interventions other Not Available completed NCT04558814
Evaluation of Serum Galectin-9 Level in Systemic Lupus Erythematosus Patients and it's Association With Disease Activity and Organ Damage No drug interventions diagnostic Not Available unknown_status NCT05146414
Clonal Hematopoiesis of Indeterminate Potential and Accelerated Atherosclerosis in Systemic Lupus Erythematosus No drug interventions Not Available Not Available completed NCT00684255
Reduced Intensity Transplant in Medically Refractory Systemic Lupus Erythematosus (SLE) and Systemic Sclerosis (SSc) treatment 1 terminated NCT04098055
Effect of Insoles in Patients With Systemic Lupus Erythematosus No drug interventions other Not Available completed NCT05260255
Effect of Vitamin D Supplement on Disease Activity in SLE treatment Not Available unknown_status NCT04022655
Predictors of Mortality in Patients With Autoimmune Diseases Admitted to the Intensive Care Unit No drug interventions Not Available Not Available unknown_status NCT01597050
Safety and Efficacy of Topical R333 in Patients With Discoid Lupus Erythematosus (DLE) and Systemic Lupus Erythematosus (SLE) Lesions No drug interventions treatment 2 completed NCT01689350
A Prospective Study of Cyclophosphamide in Systemic Lupus Erythematosus Treatment No drug interventions supportive_care Not Available completed NCT02477150
Safety and Immunogenicity of a Zoster Vaccine in SLE prevention 4 completed NCT01516450
Japanese phase1 Study of Belimumab (IV vs SC) No drug interventions basic_science 1 completed NCT00739050
Effect of Simvastatin on Endothelial Function in Premenopausal Women With Systemic Lupus Erythematosus (0733-271)(TERMINATED) treatment 4 terminated NCT06404723
The Predictive and Prognostic Values of the Fibrinogen to Albumin Ratio and C-reactive Protien to Albumin Ratio in Systemic Lupus Erythematosus Patients No drug interventions Not Available Not Available not_yet_recruiting NCT03804723
Glucocorticoids Withdrawal in Early Systemic Lupus Erythematosus treatment Not Available unknown_status NCT03098823
A Crossover Study to Compare RAYOS to IR Prednisone to Improve Fatigue and Morning Symptoms for SLE treatment 4 completed NCT06087523
Pulmonary Disease Among Patients With Systemic Lupus Erythematosus No drug interventions Not Available Not Available enrolling_by_invitation NCT00042523
Role of Antibodies in Cognitive Dysfunction in Patients With Systemic Lupus Erythematosus No drug interventions Not Available Not Available completed NCT04647708
Study of M5049 in CLE and SLE Participants treatment 1 completed NCT00035308
Safety and Efficacy Study of LJP 394 (Abetimus Sodium) to Treat Lupus Kidney Disease treatment 3 completed NCT02364908
Prospective Evaluation of Decision and Compliance With Antimalarials in Patients With Systemic Lupus No drug interventions prevention Not Available completed NCT04516408
Recombinant Zoster Vaccine in Stable SLE Patients treatment Not Available recruiting NCT05048238
Evaluation of Tofacitinib in Prevention of Photosensitivity in Lupus treatment 1 completed NCT00539838
A Study to Evaluate Two Doses of Ocrelizumab in Patients With Active Systemic Lupus Erythematosus (BEGIN) treatment 3 terminated NCT00624338
Atacicept Phase 2/3 in Generalized Systemic Lupus Erythematosus (APRIL-SLE) treatment 2 / 3 completed NCT00054938
Prevention of Atherosclerosis and Heart Disease in Patients With Systemic Lupus Erythematosis (SLE) treatment 2 completed NCT01702038
Determining the Responses and Impact of Rituximab-instigated Cell Depletion on T Cells in People With SLE treatment 2 withdrawn NCT00278538
Cyclophosphamide and Rabbit Antithymocyte Globulin (rATG)/Rituximab in Patients With Systemic Lupus Erythematosus No drug interventions treatment 2 completed NCT03537638
Multicomponent Strategy to Implement a Clinical Practice Guideline and Improve Health Outcomes in People With SLE No drug interventions health_services_research Not Available completed NCT04335643
Telehealth CBT for Adolescents and Young Adults With Childhood-onset Systemic Lupus Erythematosus No drug interventions treatment Not Available active_not_recruiting NCT00004643
Phase II Pilot Study of Cytarabine for Refractory Systemic Lupus Erythematosus treatment 2 completed NCT03187743
Personalised Pharmacological Approach to the Tapering of Corticosteroid Doses in Systemic Lupus Patients Treated With Prednisone No drug interventions treatment Not Available completed NCT06544343
Integration of Remote Monitoring in the Management of Chronic Immunosuppressive Therapy No drug interventions treatment Not Available recruiting